SR.NO. | GENERIC NAME | COMPOSITION | ||||
---|---|---|---|---|---|---|
1 | Albendazole Suspension IP | Each 5 ml contains: | ||||
Albendazole | IP | 200 | mg | |||
January 1, 1970 | In a Flavoured Syrupy base | q.s | ||||
Colour: Quinoline Yellow WS | ||||||
2 | Albendazole & Ivermectin | Each 5 ml contains: | ||||
Suspension | Albendazole | IP | 200 | mg | ||
Ivermectin | IP | 3 | mg | |||
January 1, 1970 | In a Flavoured Syrupy base | q.s | ||||
Colour: Erythrosine | ||||||
3 | Ambroxol HCl, Guaiphenesin, | Each 5 ml contains: | ||||
Terbutaline Sulphate Syrup | Ambroxol HCl | IP | 15 | mg | ||
Guaiphenesin | IP | 50 | mg | |||
January 1, 1970 | Terbutaline Sulphate | IP | 1.25 | mg | ||
Flavoured Syrupy base | q.s | |||||
Colour: Tartrazine | ||||||
4 | Ambroxol HCl, Guaiphenesin, | Each 5 ml contains: | ||||
Phenylephrine HCl & Chlorpheniramine | Ambroxol HCl | IP | 15 | mg | ||
Maleate syrup | Guaiphenesin | IP | 50 | mg | ||
Phenylephrine HCl | IP | 5 | mg | |||
Chlorpheniramine Maleate | IP | 2 | mg | |||
Flavoured Syrupy base | q.s | |||||
Colour: Caramel & Ponceau 4R | ||||||
5 | Aceclofenac & Paracetamol Suspension | Each 5 ml contains: | ||||
Aceclofenac | IP | 50 | mg | |||
Paracetamol | IP | 125 | mg | |||
In a Flavoured Syrupy base | q.s | |||||
Colour: Sunset Yellow. | ||||||
6 | Bromhexine HCl, Terbutaline Sulphate & | Each 5 ml contains: | ||||
Guaiphenesin Syrup | Bromhexine HCl | IP | 4 | mg | ||
Terbutaline Sulphate | IP | 1.25 | mg | |||
Guaiphenesin | IP | 50 | mg | |||
Flavoured Syrupy base | q.s | |||||
Colour: Sunset Yellow | ||||||
7 | Chlorhexidine Mouthwash IP | Each 5 ml contains: | ||||
Chlorhexidine Gluconate Solution | IP | |||||
eq. t oChlorhexidine Gluconate | 0.002 | w/v | ||||
In Pleasantly Flavoured aqueous base | q.s | |||||
Colour: Approved Colour | ||||||
8 | Chlorhexidine Gluconate, Sodium Fluoride & Zinc Chloride Mouthwash | Each 5 ml contains: | ||||
Chlorhexidine Gluconate Solution | IP | |||||
eq. to Chlorhexidine Gluconate | 0.002 | w/v | ||||
Sodium Fluoride | IP | 0.0005 | w/v | |||
Zinc Chloride | IP | 0.0009 | w/v | |||
In Pleasantly Flavoured aqueous base | q.s | |||||
Colour: Approved Colour | ||||||
9 | Disodium Hydrogen Citrate Syrup | Each 5 ml contains: | ||||
Disodium Hydrogen Citrate | BP | 1.4 | gm | |||
In a Flavoured Syrupy base | q.s | |||||
Colour: Tartrazine | ||||||
10 | Dicyclomine HCl & | Each 1 ml contains: | ||||
Polydimethylsiloxane Suspension | Dicyclomine HCl | IP | 10 | mg | ||
Polydimethylsiloxane | IP | 40 | mg | |||
In a Flavoured Syrupy base | q.s | |||||
Colour: Ponceau 4R | ||||||
11 | Levocetirizine Dihydrochloride, | Each 5 ml contains: | ||||
Phenylephrine HCl & Paracetamol | Levocetirizine Dihydrochloride | IP | 2.5 | mg | ||
Suspension | Phenylephrine HCl | IP | 5 | mg | ||
Paracetamol | IP | 125 | mg | |||
In a Flavoured Syrupy base | q.s | |||||
Colour: Erythrosine | ||||||
12 | Levocetirizine Dihydrochloride & | Each 5 ml contains: | ||||
Montelukast Sodium Suspension | Levocetirizine Dihydrochloride | IP | 2.5 | mg | ||
Montelukast Sodium | IP | |||||
eq. to Montelukast | 4 | mg | ||||
In a Flavoured Syrupy base | q.s | |||||
Colour: Sunset Yellow. | ||||||
13 | Mefenamic Acid & Paracetamol | Each 5 ml contains: | ||||
Suspension | Mefenamic Acid | IP | 50 | mg | ||
Paracetamol | IP | 125 | mg | |||
In a Flavoured Syrupy base | q.s | |||||
Colour: Sunset Yellow. | ||||||
14 | Megaldrate, Simethicone & | Each 5 ml contains: | ||||
Oxetacaine Suspension | Megaldrate | IP | 540 | mg | ||
Simethicone | IP | 50 | mg | |||
January 1, 1970 | Oxetacaine | BP | 10 | mg | ||
Sorbital base | q.s | |||||
Colour: Erythrosine | ||||||
15 | Ofloxacin Oral Suspension IP | Each 5 ml contains: | ||||
Ofloxacin | IP | 50 | mg | |||
January 1, 1970 | In a Palatable base | q.s | ||||
Colour: Sunset yellow FCF | ||||||
16 | Ondensetron Oral Suspension IP | Each 1 ml contains: | ||||
Ondensetron HCl | IP | |||||
eq. to Ondensetron | 2 | mg | ||||
Flavoured Syrupy base | q.s | |||||
Colour: Ponceau 4R | ||||||
17 | Phenylephrine HCl, | Each 5 ml contains: | ||||
Chlorpheniramine Maleate Syrup | Phenylephrine HCl | IP | 2.5 | mg | ||
Chlorpheniramine Maleate | IP | 1 | mg | |||
January 1, 1970 | In a Flavoured palatable base | q.s | ||||
Colour: Ponceau 4R | ||||||
18 | Paracetamol, Phenylephrine HCl, | Each 5 ml contains: | ||||
Chlorpheniramine Maleate & Sodium | Paracetamol | IP | 250 | mg | ||
Citrate Oral Suspension | Phenylephrine HCl | IP | 5 | mg | ||
Chlorpheniramine Maleate | IP | 2 | mg | |||
Sodium Citrate | IP | 60 | mg | |||
In Flavoured mentholated suspension base | ||||||
Colour: Sunset yellow FCF | ||||||
19 | Sucralfate & Oxetacaine Suspension | Each 10 ml contains: | ||||
Sucralfate | USP | 1 | gm | |||
Oxetacaine | BP | 20 | mg | |||
In a Flavoured palatable base | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
20 | Sucralfate Suspension | Each 10 ml contains: | ||||
Sucralfate | USP | 1 | gm | |||
In a Flavoured palatable base | q.s | |||||
Colour: Tartrazine | ||||||
21 | Terbutaline Sulphate, Ambroxol HCl & | Each 5 ml contains: | ||||
Guaiphenesin Cough Expectorants | Terbutaline Sulphate | IP | 1.25 | mg | ||
Ambroxol HCl | IP | 15 | mg | |||
Guaiphenesin | IP | 50 | mg | |||
Flavoured Syrupy base | q.s | |||||
Colour: Brilliant Blue | ||||||
22 | Cyproheptadine & Tricholine Citrate Syrup | Each 5 ml contains: | ||||
Cyproheptadine Hydrochloride | IP | 2 | mg | |||
Tricholine Citrate | 275 | mg | ||||
Flavoured Syrupy base | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
23 | Iron tonic with Vitamin B12 and folic Acid | Each 5 ml contains: | ||||
Ferric Ammonium Citrate | IP | 80 | mg | |||
Folic Acid | IP | 0.166 | mg | |||
January 1, 1970 | Vitamin B12 | IP | 1 | mcg | ||
Flavoured Syrupy base | q.s | |||||
Colour: Caramel | ||||||
24 | Iron, folic Acid,Vitamin B12 & Vitamin B6 Oral Drops | Each 5 ml contains: | ||||
Ferric Ammonium Citrate | IP | 150 | mg | |||
(eq. to Elemental Iron 30 mg) | ||||||
Folic Acid | IP | 0.2 | mg | |||
January 1, 1970 | Vitamin B12 | IP | 5 | mcg | ||
Vitamin B6 | IP | 1 | mg | |||
Flavoured palatable base | q.s | |||||
Colour: Carmosine | ||||||
25 | Multi Vitamin And Multi Mineral Syrup | Each 5 ml contains: | ||||
Protein Hydrolysate 20% | 0.333 | gm | ||||
Prridoxine Hcl | IP | 0.5 | mg | |||
Niacinamide | IP | 15 | mg | |||
Iron Choline citrate | 15 | mcg | ||||
Magnisium Chloride | IP | 3.33 | mg | |||
Manganese Chloride | USP | 0.03 | mg | |||
Zinc Sulphate | IP | 44 | mg | |||
eq. to elemental Zinc | ||||||
L-Lysine Hydrochloride | USP | 20 | mg | |||
Flavoured syrupy base | q.s | |||||
Colour: Caramal | ||||||
26 | Roxythromycin Suspension | Each 5 ml contains: | ||||
Roxythromycin | IP | 50 | mg | |||
January 1, 1970 | Flavoured Syrupy base | q.s | ||||
Colour: Sunset Yellow FCF | ||||||
27 | Azithromycin Oral Suspension IP | Each 5 ml contains: | ||||
Azithromycin Dihydrate | IP | |||||
Eq. to Azithromycin | 200 | mg | ||||
January 1, 1970 | Flavoured Syrupy base | q.s | ||||
Colour: Quinoline Yellow WS | ||||||
28 | Azithromycin Oral Suspension IP | Each 5 ml contains: | ||||
Azithromycin Dihydrate | IP | |||||
Eq. to Azithromycin | 100 | mg | ||||
January 1, 1970 | Flavoured Syrupy base | q.s | ||||
Colour: Tartrazine | ||||||
29 | Albendazole Tablets IP | Each uncoated chewable tablet contains: | ||||
Albendazole | IP | 400 | mg | |||
Excipients | q.s | |||||
Colour: Sunset Yellow | ||||||
30 | Albendazole & Ivermectin Tablets | Each uncoated chewable tablet contains: | ||||
Albendazole | IP | 400 | mg | |||
Ivermectin | IP | 6 | mg | |||
Excipients | q.s | |||||
Colour: Sunset Yellow | ||||||
31 | Allopurinol Tablets IP | Each uncoated tablet contains: | ||||
Allopurinol | IP | 100 | mg | |||
Excipients | q.s | |||||
32 | Allopurinol Tablets IP | Each uncoated tablet contains: | ||||
Allopurinol | IP | 300 | mg | |||
Excipients | q.s | |||||
33 | Atenolol Tablets IP | Each film coated tablet contains: | ||||
Atenolol | IP | 50 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Sunset Yellow & Titanium Dioxide IP | ||||||
34 | Aceclofenac & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Aceclofenac | IP | 100 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
Colour: Erythrosine | ||||||
35 | Aceclofenac & Paracetamol Tablets | Each film coated tablet contains: | ||||
Aceclofenac | IP | 100 | mg | |||
Paracetamol | IP | 325 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Yellow Oxide of Iron | ||||||
36 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each uncoated tablet contains: | ||||
Aceclofenac | IP | 100 | mg | |||
Paracetamol | IP | 325 | mg | |||
Chlorzoxazone | USP | 250 | mg | |||
Excipients | q.s | |||||
37 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each filmcoated tablet contains: | ||||
Aceclofenac | IP | 100 | mg | |||
Paracetamol | IP | 325 | mg | |||
Chlorzoxazone | USP | 250 | mg | |||
Excipients | q.s | |||||
Colours: Sunset Yellow FCF | ||||||
38 | Artemether & Lumefantrine Tablets | Each uncoated tablet contains: | ||||
Artemether | IP | 80 | mg | |||
January 1, 1970 | Lumefantrine | 480 | mg | |||
Excipients | q.s | |||||
Colour: Tartrazine | ||||||
39 | Aceclofenac & Paracetamol Tablets | Each film coated tablet contains: | ||||
Aceclofenac | IP | 100 | mg | |||
Paracetamol | IP | 325 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
40 | Chlorpheniramine Maleate Tablets IP | Each uncoated tablet contains: | ||||
Chlorpheniramine Maleate | IP | 4 | mg | |||
Excipients | q.s | |||||
41 | Clopidogrel Tablets IP | Each film coated tablet contains: | ||||
Clopidogrel | IP | 75 | mg | |||
Excipients | q.s. | |||||
Colours: Tartrazine & Titanium Dioxide IP | ||||||
42 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
Ciprofloxacin Hydrochloride | IP | |||||
January 1, 1970 | Eq. to Ciprofloxacin | 250 | mg | |||
Excipients | q.s | |||||
Colour: Quinoline Yellow Lake & Titanium Dioxide IP | ||||||
43 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
Ciprofloxacin Hydrochloride | IP | |||||
January 1, 1970 | Eq. to Ciprofloxacin | 250 | mg | |||
Excipients | q.s | |||||
Colour: Titanium Dioxide IP | ||||||
44 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
Ciprofloxacin Hydrochloride | IP | |||||
January 1, 1970 | Eq. to Ciprofloxacin | 250 | mg | |||
Excipients | q.s | |||||
Colour: Titanium Dioxide IP & Red Oxide Of Iron | ||||||
45 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
Ciprofloxacin Hydrochloride | IP | |||||
January 1, 1970 | Eq. to Ciprofloxacin | 500 | mg | |||
Excipients | q.s | |||||
Colour: Titanium Dioxide IP | ||||||
46 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
Ciprofloxacin Hydrochloride | IP | |||||
January 1, 1970 | Eq. to Ciprofloxacin | 500 | mg | |||
Excipients | q.s | |||||
Colour: Quinoline Yellow | ||||||
47 | Ciprofloxacin Tablets IP | Each film coated tablet contains: | ||||
Ciprofloxacin Hydrochloride | IP | |||||
Eq. to Ciprofloxacin | 500 | mg | ||||
Excipients | q.s | |||||
Colour: Titanium Dioxide IP & Red Oxide Of Iron | ||||||
48 | Ciprofloxacin & Tinidazole Tablets | Each film coated tablet contains: | ||||
Ciprofloxacin Hydrochloride | IP | |||||
Eq. to Ciprofloxacin | 500 | mg | ||||
Tinidazole | IP | 600 | mg | |||
Excipients | q.s | |||||
Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
49 | Clotrimazole & Tinidazole Vaginal Tablets | Each uncoated vaginal tablet contains: | ||||
Clotrimazole | IP | 200 | mg | |||
January 1, 1970 | Tinidazole | IP | 600 | mg | ||
Excipients | q.s | |||||
50 | Clotrimazole, Tinidazole & Povidone Iodine Vaginal Tablets | Each uncoated vaginal tablet contains: | ||||
Clotrimazole | IP | 200 | mg | |||
January 1, 1970 | Tinidazole | IP | 600 | mg | ||
Povidone Iodine | IP | 200 | mg | |||
Excipients | q.s | |||||
51 | Cyproheptadine Hydrochloride Tablets IP | Each uncoated tablet contains: | ||||
Cyproheptadine Hydrochloride | IP | 4 | mg | |||
Excipients | q.s | |||||
52 | Diclofenac Sodium Tablets IP | Each enteric coated tablet contains: | ||||
Diclofenac Sodium | IP | 50 | mg | |||
Excipients | q.s | |||||
Colour: Sunset yellow & Titanium Dioxide IP | ||||||
53 | Diclofenac Prolonged-release Tablets IP | Each film coated prolonged-Release tablet contains: | ||||
Diclofenac Sodium | IP | 100 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
54 | Diclofenac Sodium & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Diclofenac Sodium | IP | 50 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
Colours: Brilliant Blue | ||||||
55 | Diclofenac Sodium, Paracetamol & Chlorzoxazone Tablets | Each uncoated tablet contains: | ||||
Diclofenac Sodium | IP | 50 | mg | |||
January 1, 1970 | Paracetamol | IP | 325 | mg | ||
Chlorzoxazone | USP | 250 | mg | |||
Excipients | q.s | |||||
Colours:Quinoline Yellow | ||||||
57 | Drotaverine & Mefenamic Acid Tablets | Each filmcoated tablet contains: | ||||
Drotaverine Hydrochloride | IP | |||||
Eq. to Drotaverine | 40 | mg | ||||
Mefenamic Acid | IP | 250 | mg | |||
Excipients | q.s. | |||||
Colours: Sunset Yellow & Titanium Dioxide IP | ||||||
58 | Deflazacort Tablets | Each film coated tablet contains: | ||||
Deflazacort | 6 | mg | ||||
Excipients | q.s. | |||||
Colours: Tartrazine & Titanium Dioxide IP | ||||||
59 | Deflazacort Tablets | Each film coated tablet contains: | ||||
Deflazacort | 30 | mg | ||||
Excipients | q.s. | |||||
Colours: Tartrazine & Titanium Dioxide IP | ||||||
60 | Dicyclomine Hydrochloride & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Dicyclomine Hydrochloride | IP | 20 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
61 | Dicyclomine Hydrochloride & Mefenamic Acid Tablets | Each uncoated tablet contains: | ||||
Dicyclomine Hydrochloride | IP | 10 | mg | |||
Mefenamic Acid | IP | 250 | mg | |||
Excipients | q.s | |||||
Colour: Tartrazine | ||||||
62 | Etoricoxib Tablets IP | Each film coated tablet contains: | ||||
Etoricoxib | IP | 60 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Brilliant Blue, Tartrazine & Titanium Dioxide IP | ||||||
63 | Etoricoxib Tablets IP | Each film coated tablet contains: | ||||
Etoricoxib | IP | 90 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Brilliant Blue, Tartrazine & Titanium Dioxide IP | ||||||
64 | Etoricoxib Tablets IP | Each film coated tablet contains: | ||||
Etoricoxib | IP | 120 | mg | |||
Excipients | q.s | |||||
Colours: Brilliant Blue, Tartrazine & Titanium Dioxide IP | ||||||
65 | Etoricoxib & Paracetamol Tablets | Each film coated tablet contains: | ||||
Etoricoxib | IP | 60 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
Colours: Brilliant Blue, Tartrazine & Titanium Dioxide IP | ||||||
66 | Etamsylate Tablets | Each uncoated tablet contains: | ||||
January 1, 1970 | Etamsylate | BP | 500 | mg | ||
Excipients | q.s | |||||
67 | Ethambutol Hydrochloride Tablets IP | Each film coated tablet contains: | ||||
Ethambutol Hydrochloride | IP | 800 | mg | |||
Excipients | q.s | |||||
Colour: Titanium Dioxide IP | ||||||
68 | Fluconazole Tablets IP | Each uncoated tablet contains: | ||||
Fluconazole | IP | 150 | mg | |||
Excipients | q.s | |||||
Colours: Ponceau 4R | ||||||
69 | Fexofenadine Hydrochloride & Montelukast Tablets | Each film coated tablet contains: | ||||
Fexofenadine Hydrochloride | IP | 120 | mg | |||
Montelukast Sodium | IP | |||||
Eq. to Montelukast | 10 | mg | ||||
Excipients | q.s. | |||||
Colours: Tartrazine & Titanium Dioxide IP | ||||||
70 | Famotidine Tablets IP | Each film coated tablet contains: | ||||
Famotidine | IP | 20 | mg | |||
Excipients | q.s | |||||
Colour: Brilliant Blue FCF | ||||||
71 | Gliclazide & Metformin Hydrochloride Tablets | Each uncoated tablet contains: | ||||
Gliclazide | IP | 80 | mg | |||
Metformin Hydrochloride | IP | 500 | mg | |||
Excipients | q.s | |||||
72 | Glimipride & Metformin Tablets | Each uncoated tablet contains: | ||||
Glimipride | IP | 2 | mg | |||
Metformin Hydrochloride | IP | 500 | mg | |||
Excipients | q.s. | |||||
73 | Ibuprofen & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Ibuprofen | IP | 400 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
74 | Lornoxichem & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Lornoxichem | IP | 8 | mg | |||
January 1, 1970 | Paracetamol | IP | 325 | mg | ||
Excipients | q.s | |||||
75 | Linezolid Tablets IP | Each filmcoated tablet contains: | ||||
January 1, 1970 | Linezolid | IP | 600 | mg | ||
Excipients | q.s | |||||
Colours: Tartrazine & Titanium Dioxide IP | ||||||
76 | Loratidine Tablets BP | Each filmcoated tablet contains: | ||||
Loratidine | BP | 10 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Erythrosine | ||||||
77 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
Levofloxacin Hemihydrate | IP | |||||
Eq. to Levofloxacin | 750 | mg | ||||
Excipients | q.s | |||||
Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
78 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
Levofloxacin Hemihydrate | IP | |||||
Eq. to Levofloxacin | 750 | mg | ||||
Excipients | q.s | |||||
Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
79 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
Levofloxacin Hemihydrate | IP | |||||
Eq. to Levofloxacin | 750 | mg | ||||
Excipients | q.s | |||||
Colours: Titanium Dioxide IP | ||||||
80 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
Levofloxacin Hemihydrate | IP | |||||
Eq. to Levofloxacin | 500 | mg | ||||
Excipients | q.s | |||||
Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
81 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
Levofloxacin Hemihydrate | IP | |||||
January 1, 1970 | Eq. to Levofloxacin | 500 | mg | |||
Excipients | q.s | |||||
Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
82 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
Levofloxacin Hemihydrate | IP | |||||
Eq. to Levofloxacin | 250 | mg | ||||
Excipients | q.s | |||||
Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
83 | Levofloxacin Tablets IP | Each film coated tablet contains: | ||||
Levofloxacin Hemihydrate | IP | |||||
January 1, 1970 | Eq. to Levofloxacin | 250 | mg | |||
Excipients | q.s | |||||
Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
84 | Levofloxacin & Ornidazole Tablets | Each film coated tablet contains: | ||||
Levofloxacin Hemihydrate | IP | |||||
January 1, 1970 | Eq. to Levofloxacin | 250 | mg | |||
Ornidazole | IP | 500 | mg | |||
Excipients | q.s | |||||
Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
85 | Levocetirizine Dihydrochloride Tablets IP | Each Film coated tablet contains: | ||||
Levocetirizine Di Hydrochloride | IP | 5 | mg | |||
Excipients | q.s | |||||
Colour: Titanium Dioxide IP | ||||||
86 | Levocetirizine Dihydrochloride Tablets IP | Each Film coated tablet contains: | ||||
Levocetirizine Di Hydrochloride | IP | 10 | mg | |||
Excipients | q.s | |||||
Colour: Quinoline Yellow & Titanium Dioxide IP | ||||||
87 | Levocetirizine Di HCl & Ambroxol HCl Tablets | Each film coated tablet contains: | ||||
Levocetirizine Di Hydrochloride | IP | 5 | mg | |||
January 1, 1970 | Ambroxol Hydrochloride | IP | 60 | mg | ||
Excipients | q.s | |||||
Colour: Titanium Dioxide IP | ||||||
88 | Loperamide HCl Tablets IP | Each uncoated tablet contains: | ||||
Loperamide Hydrochloride | IP | 2 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Brilliant Blue & Titanium Dioxide IP | ||||||
89 | Montelukast Sodium & Levocetirizine HCl Tablets | Each film coated tablet contains: | ||||
Montelukast Sodium | IP | |||||
Eq. to Montelukast | 10 | mg | ||||
January 1, 1970 | Levocetirizine Di Hydrochloride | IP | 5 | mg | ||
Excipients | q.s | |||||
Colours: Quinoline Yellow & Titanium Dioxide IP | ||||||
90 | Montelukast Sodium, Ambroxol & Levocetirizine HCl Tablets | Each film coated tablet contains: | ||||
Montelukast Sodium | IP | |||||
Eq. to Montelukast | 10 | mg | ||||
Levocetirizine Di Hydrochloride | IP | 5 | mg | |||
January 1, 1970 | Ambroxol Hydrochloride | IP | 15 | mg | ||
Excipients | q.s | |||||
Colours: Tartrazine & Titanium Dioxide IP | ||||||
91 | Mefenamic Acid Tablets BP | Each uncoated tablet contains: | ||||
Mefenamic Acid | IP | 500 | mg | |||
Excipients | q.s | |||||
92 | Mefenamic Acid & Tranexamic Acid Tablets | Each film coated tablet contains: | ||||
Mefenamic Acid | IP | 250 | mg | |||
Tranexamic Acid | USP | 500 | mg | |||
Excipients | q.s. | |||||
Colours: Sunset Yellow & Titanium Dioxide IP | ||||||
93 | Metoclopramide HCl Tablets IP | Each uncoated tablet contains: | ||||
Metoclopramide HCl | IP | |||||
Eq. to anhydrous Metoclopramide HCl | 10 | mg | ||||
Excipients | q.s | |||||
94 | Metoclopramide HCl & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Metoclopramide HCl | IP | |||||
Eq. to anhydrous Metoclopramide HCl | 5 | mg | ||||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
95 | Mefenamic Acid Tablets BP | Each uncoated tablet contains: | ||||
January 1, 1970 | Mefenamic Acid | IP | 250 | mg | ||
Excipients | q.s | |||||
96 | Norfloxacin Tablets IP | Each film coated tablet contains: | ||||
Norfloxacin | IP | 400 | mg | |||
Excipients | q.s | |||||
Colours: Tartrazine & Titanium Dioxide IP | ||||||
97 | Norfloxacin & Tinidazole Tablets | Each film coated tablet contains: | ||||
Norfloxacin | IP | 400 | mg | |||
Tinidazole | IP | 600 | mg | |||
Excipients | q.s | |||||
Colours: Tartrazine & Titanium Dioxide IP | ||||||
98 | Nimesulide Tablets | Each uncoated tablet contains: | ||||
January 1, 1970 | Nimesulide | BP | 100 | mg | ||
Excipients | q.s | |||||
99 | Nimesulide & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Nimesulide | BP | 100 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
100 | Nimesulide, Paracetamol & Chlorzoxazone Tablets | Each uncoated tablet contains: | ||||
Nimesulide | BP | 100 | mg | |||
January 1, 1970 | Paracetamol | IP | 325 | mg | ||
Chorzoxazone | USP | 375 | mg | |||
Excipients | q.s | |||||
Colour:Quinoline Yellow WS | ||||||
101 | Ofloxacin Tablets IP | Each film coated tablet contains: | ||||
Ofloxacin | IP | 400 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colour: Quinoline Yellow | ||||||
102 | Ofloxacin Tablets IP | Each film coated tablet contains: | ||||
Ofloxacin | IP | 200 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colour: Titanium Dioxide IP | ||||||
104 | Ofloxacin Tablets IP | Each film coated tablet contains: | ||||
Ofloxacin | IP | 200 | mg | |||
Excipients | q.s | |||||
Colour: Quinoline Yellow | ||||||
105 | Ofloxacin Dispersible Tablets | Each uncoatd dispersible tablet contains: | ||||
Ofloxacin | IP | 100 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colour: Red Oxide of Iron | ||||||
106 | Ofloxacin & Tinidazole Tablets | Each filmcoated tablet contains: | ||||
Ofloxacin | IP | 200 | mg | |||
January 1, 1970 | Tinidazole | IP | 600 | mg | ||
Excipients | q.s | |||||
Colours: Quinoline Yellow & Titanium Dioxide IP | ||||||
107 | Ornidazole Tablets IP | Each film coated tablet contains: | ||||
Ornidazole | IP | 500 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colour: Titanium Dioxide IP | ||||||
108 | Ondansetron Orally Disintegrating Tablets IP | Each uncoated Orally Disintegrating tablet contains: | ||||
Ondansetron Hydrochloride | IP | |||||
January 1, 1970 | Eq. to Ondansetron | 4 | mg | |||
Excipients | q.s | |||||
109 | Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
Paracetamol | IP | 500 | mg | |||
Excipients | q.s | |||||
110 | Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
Paracetamol | IP | 650 | mg | |||
Excipients | q.s | |||||
111 | Paracetamol & Caffeine Tablets | Each uncoated tablet contains: | ||||
Paracetamol | IP | 500 | mg | |||
January 1, 1970 | Caffeine | IP | 30 | mg | ||
Excipients | q.s | |||||
Colour: Red Oxide of Iron | ||||||
112 | Paracetamol, Phenylepherine HCl , Chlorpheniramine Maleate & Caffeine Tablets | Each uncoated tablet contains: | ||||
Paracetamol | IP | 325 | mg | |||
Phenylepherine Hydrochloride | IP | 5 | mg | |||
January 1, 1970 | Chlorpheniramine Maleate | IP | 2 | mg | ||
Caffeine (anhydrous) | IP | 30 | mg | |||
Excipients | q.s | |||||
Colour: Quinoline Yellow WS | ||||||
113 | Paracetamol, Phenylepherine HCl & Cetirizine HCl Tablets | Each uncoated tablet contains: | ||||
Paracetamol | IP | 325 | mg | |||
January 1, 1970 | Phenylepherine Hydrochloride | IP | 5 | mg | ||
Cetirizine Hydrochloride | IP | 5 | mg | |||
Excipients | q.s | |||||
114 | Paracetamol, Phenylepherine HCl & Cetirizine HCl Tablets | Each uncoated tablet contains: | ||||
Paracetamol | IP | 325 | mg | |||
January 1, 1970 | Phenylepherine Hydrochloride | IP | 5 | mg | ||
Cetirizine Hydrochloride | IP | 5 | mg | |||
Excipients | q.s | |||||
Colour: Quinoline Yellow WS | ||||||
115 | Paracetamol, Phenylepherine HCl , Chlorpheniramine Maleate, Guaiphenesin & Bromhexine HCl Tablets | Each uncoated tablet contains: | ||||
Paracetamol | IP | 325 | mg | |||
Phenylepherine Hydrochloride | IP | 10 | mg | |||
January 1, 1970 | Chlorpheniramine Maleate | IP | 2 | mg | ||
Guaiphenesin | IP | 100 | mg | |||
Bromhexine HCl | IP | 8 | mg | |||
Excipients | q.s | |||||
Colour: Tartrazine | ||||||
116 | Pheniramine Maleate Tablets IP | Each uncoated tablet contains: | ||||
January 1, 1970 | Pheniramine Maleate | IP | 25 | mg | ||
Excipients | q.s | |||||
117 | Pantoprazole Gastro-resistant Tablets IP | Each enteric coated tablet contains: | ||||
Pantoparazole Sodium Sesquihydrate | IP | |||||
January 1, 1970 | Eq. to Pantoprazole | 40 | mg | |||
Excipients | q.s | |||||
Colours: Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
118 | Pantoprazole Sodium & Domperidone Tablets | Each enteric coated tablet contains: | ||||
Pantoparazole Sodium Sesquihydrate | IP | |||||
Eq. to Pantoprazole | 20 | mg | ||||
Domperidone | IP | 10 | mg | |||
Excipients | q.s | |||||
Colour: Tartrazine | ||||||
119 | Pantoprazole Sodium & Domperidone Tablets | Each enteric coated tablet contains: | ||||
Pantoparazole Sodium Sesquihydrate | IP | |||||
Eq. to Pantoprazole | 40 | mg | ||||
Domperidone | IP | 10 | mg | |||
Excipients | q.s | |||||
Colour: Tartrazine | ||||||
120 | Pantoprazole Sodium & Domperidone Tablets | Each enteric coated tablet contains: | ||||
Pantoparazole Sodium Sesquihydrate | IP | |||||
January 1, 1970 | Eq. to Pantoprazole | 40 | mg | |||
Domperidone | IP | 10 | mg | |||
Excipients | q.s | |||||
Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
121 | Piroxicam Dispersible Tablets | Each uncoated dispersible tablet contains: | ||||
Piroxicam | IP | 20 | mg | |||
Excipients | q.s | |||||
122 | Pyrazinamide Tablets IP | Each uncoated tablet contains: | ||||
Pyrazinamide | IP | 750 | mg | |||
Excipients | q.s. | |||||
123 | Prochloperazine Maleate Tablets IP | Each uncoated mouth Dissolving tablet contains: | ||||
Prochloperazine Maleate | IP | 5 | mg | |||
Excipients | q.s | |||||
124 | Prochlorperazine Maleate & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Prochlorperazine Maleate | IP | 5 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
125 | Ranitidine Tablets IP | Each film coated tablet contains: | ||||
Ranitidine Hydrochloride | IP | |||||
January 1, 1970 | Eq. to Ranitidine | 150 | mg | |||
Excipients | q.s | |||||
Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
126 | Ranitidine Tablets IP | Each film coated tablet contains: | ||||
Ranitidine Hydrochloride | IP | |||||
January 1, 1970 | Eq. to Ranitidine | 150 | mg | |||
Excipients | q.s | |||||
Colours: Brilliant Blue , Tartrazine & Titanium Dioxide IP | ||||||
127 | Ranitidine & Domperidone Tablets | Each film coated tablet contains: | ||||
Ranitidine Hydrochloride | IP | |||||
Eq. to Ranitidine | 150 | mg | ||||
January 1, 1970 | Domperidone | IP | 10 | mg | ||
Excipients | q.s | |||||
Colours: Sunset Yellow FCF & Titanium Dioxide IP | ||||||
128 | Rabeprazole Gastro-resistant Tablets IP | Each enteric coated tablet contains: | ||||
Rabeprazole Sodium | IP | 20 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
129 | Rabeprazole Sodium & Domperidone Tablets | Each enteric coated tablet contains: | ||||
Rabeprazole Sodium | IP | 20 | mg | |||
Domperidone | IP | 10 | mg | |||
Excipients | q.s | |||||
Colours: Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
130 | Roxithromycin & Ambroxol Tablets | Each film coated tablet contains: | ||||
Roxithromycin | IP | 150 | mg | |||
Ambroxol Hydroxide | IP | 30 | mg | |||
Excipients | q.s. | |||||
Colours: Brilliant Blue & Titanium Dioxide IP | ||||||
131 | Rifampicin & Isoniazid Tablets IP | Each film coated tablet contains: | ||||
Rifampicin | IP | 450 | mg | |||
January 1, 1970 | Isoniazid | IP | 300 | mg | ||
Excipients | q.s | |||||
Colours: Red Oxide of Iron | ||||||
132 | Tinidazole Tablets IP | Each film coated tablet contains: | ||||
Tinidazole | IP | 500 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Quninoline Yellow, Yellow Oxide of iron & Titanium Dioxide IP | ||||||
133 | Triprolidine HCl & Phenylphrine HCl Tablets | Each uncoated tablet contains: | ||||
Triprolidine Hydrochloride | IP | 2.5 | mg | |||
January 1, 1970 | Phenylphrine Hydrochloride | IP | 5 | mg | ||
Excipients | q.s | |||||
134 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: | ||||
Ursodeoxycholic Acid | IP | 300 | mg | |||
Excipients | q.s. | |||||
Colours: Sunset Yellow & Titanium Dioxide IP | ||||||
135 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: | ||||
Ursodeoxycholic Acid | IP | 150 | mg | |||
Excipients | q.s. | |||||
Colours: Sunset Yellow & Titanium Dioxide IP | ||||||
136 | Cetirizine Hydrochloride Tablets IP | Each film coated tablet contains: | ||||
Cetirizine Hydrochloride | IP | 10 | mg | |||
Excipients | q.s | |||||
Colour: Titanium Dioxide IP | ||||||
137 | Amoxycillin Dispersible Tablets IP | Each uncoated Dispersible tablet contains: | ||||
Amoxycillin Trihydrate | IP | |||||
eq. to Amoxycillin | 125 | mg | ||||
Excipients | q.s. | |||||
138 | Amoxycillin Dispersible Tablets IP | Each uncoated Dispersible tablet contains: | ||||
Amoxycillin Trihydrate | IP | |||||
January 1, 1970 | eq. to Amoxycillin | 250 | mg | |||
Excipients | q.s. | |||||
139 | Azithromycin Tablets IP 250 mg | Each film coated tablet contains: | ||||
Azithromycin dihydrate | IP | |||||
eq. to Anhydrous Azithromycin | 250 | mg | ||||
Excipients | q.s. | |||||
Colour: Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
140 | Azithromycin Tablets IP 500 mg | Each film coated tablet contains: | ||||
Azithromycin dihydrate | IP | |||||
eq. to Anhydrous Azithromycin | 500 | mg | ||||
Excipients | q.s. | |||||
Colour: Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
141 | Aceclofenac, Paracetamol | Each film coated tablet contains: | ||||
& Serratiopeptidase tablets | Aceclofenac | IP | 100 | mg | ||
Paracetamol | IP | 325 | mg | |||
Serratiopeptidase (30,000 units of Serratiopeptidase as enteric coated granules) | IP | 15 | mg | |||
Excipients | q.s. | |||||
Colour: Tartrazine & Titanium Dioxide IP | ||||||
142 | Betamethasone Sodium Phosphate | Each uncoated tablet contains: | ||||
Tablets IP | Betamethasone Sodium Phosphate | IP | ||||
eq. to Betamethasone | 0.5 | mg | ||||
January 1, 1970 | Excipients | q.s. | ||||
Colour: Erythrosine | ||||||
143 | Cefixime Dispersible Tablets | Each uncoated dispersible tablet contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Anhydrous Cefixime | 100 | mg | ||||
Excipients | q.s. | |||||
144 | Cefixime Dispersible Tablets | Each Uncoated Dispersible tablet contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Cefixime (Anhydrous) | 200 | mg | ||||
Excipients | q.s. | |||||
145 | Cefixime Trihydrate Tablets IP | Each film coated tablet contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Anhydrous Cefixime | 200 | mg | ||||
Excipients | q.s. | |||||
Colour: Titanium Dioxide IP | ||||||
146 | Cefixime Tablets IP | Each film coated tablet contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Anhydrous Cefixime | 400 | mg | ||||
Excipients | q.s. | |||||
Colour: Titanium Dioxide IP | ||||||
147 | Cefixime & Ofloxacin tablets | Each film coated tablet contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Anhydrous Cefixime | 200 | mg | ||||
January 1, 1970 | Ofloxacin | IP | 200 | mg | ||
Excipients | q.s. | |||||
Colour: Quinoline Yellow & Titanium Dioxide IP | ||||||
148 | Cefpodoxime Proxetil Dispersible | Each uncoated dispersible tablet contains: | ||||
Tablets | Cefpodoxime Proxetil | IP | ||||
eq. to Cefpodoxime | 100 | mg | ||||
Excipients | q.s. | |||||
149 | Cefpodoxime Proxetil Dispersible | Each uncoated dispersible tablet contains: | ||||
Tablets | Cefpodoxime Proxetil | IP | ||||
eq. to Cefpodoxime | 200 | mg | ||||
Excipients | q.s. | |||||
150 | Cefpodoxime & Ofloxacin tablets | Each film coated tablet contains: | ||||
Cefpodoxime Proxetil | IP | |||||
eq. to Cefpodoxime | 200 | mg | ||||
Ofloxacin | IP | 200 | mg | |||
Excipients | q.s. | |||||
Colour: Tartrazine & Titanium Dioxide IP | ||||||
151 | Cefuroxime Axetil Tablet IP | Each film coated tablet contains: | ||||
Cefuroxime Axetil | IP | |||||
eq. to Cefuroxime | 250 | mg | ||||
Excipients | q.s. | |||||
Colour: Titanium Dioxide IP | ||||||
152 | Cefuroxime Axetil Tablet IP | Each film coated tablet contains: | ||||
Cefuroxime Axetil | IP | |||||
January 1, 1970 | eq. to Cefuroxime | 500 | mg | |||
Excipients | q.s. | |||||
Colour: Titanium Dioxide IP | ||||||
153 | Cefuroxime Axetil & Linzolid Tablet | Each film coated tablet contains: | ||||
Cefuroxime Axetil | IP | |||||
eq. to Cefuroxime | 500 | mg | ||||
January 1, 1970 | Linzolid | IP | 600 | mg | ||
Excipients | q.s. | |||||
154 | Diclofenac Potassium & | Each film coated tablet contains: | ||||
Serratiopeptidase tablets | Diclofenac Potassium | BP | 50 | mg | ||
January 1, 1970 | Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | ||
Excipients | q.s. | |||||
Colour: Titanium Dioxide IP | ||||||
155 | Diclofenac Sodium & | Each film coated tablet contains: | ||||
Serratiopeptidase tablets | Diclofenac Sodium | IP | 50 | mg | ||
January 1, 1970 | Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | ||
Excipients | q.s. | |||||
Colour: Sunset Yellow & Titanium Dioxide IP | ||||||
156 | Folic Acid Tablets IP | Each uncoated tablet contains: | ||||
January 1, 1970 | Folic Acid | IP | 5 | mg | ||
Excipients | q.s. | |||||
157 | Levonorgestrel Tablets IP | Each film coated tablet contains: | ||||
Levonorgestrel | IP | 1.5 | mg | |||
January 1, 1970 | Excipients | q.s. | ||||
Colour: Erythrosine & Titanium Dioxide IP | ||||||
158 | Methylergometrine Maleate Tablets IP | Each film coated tablet contains: | ||||
Methylergometrine Maleate | IP | 0.125 | mg | |||
January 1, 1970 | Excipients | q.s. | ||||
Colour: Titanium Dioxide IP | ||||||
159 | Norethisterone Tablets IP | Each uncoated tablet contains: | ||||
Norethisterone | IP | 5 | mg | |||
Excipients | q.s. | |||||
160 | Paracetamol, Diclofenac Sodium | Each film coated tablet contains: | ||||
& Serratiopeptidase tablets | Paracetamol | IP | 325 | mg | ||
Diclofenac Sodium | IP | 50 | mg | |||
January 1, 1970 | Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | ||
Excipients | q.s. | |||||
Colour: Tartrazine | ||||||
161 | Paracetamol, Diclofenac Potassium | Each film coated tablet contains: | ||||
& Serratiopeptidase tablets | Paracetamol | IP | 325 | mg | ||
Diclofenac Potassium | BP | 50 | mg | |||
January 1, 1970 | Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | ||
Excipients | q.s. | |||||
Colour: Sunset Yellow & Titanium Dioxide IP | ||||||
162 | Roxithromycin Tablets IP | Each uncoated dispersible tablet contains: | ||||
Roxithromycin | IP | 50 | mg | |||
January 1, 1970 | Excipients | q.s. | ||||
Colour:Sunset yellow FCF | ||||||
163 | Roxithromycin Tablets IP | Each film coated tablet contains: | ||||
Roxithromycin | IP | 150 | mg | |||
January 1, 1970 | Excipients | q.s. | ||||
Colour: Brilliant Blue FCF | ||||||
164 | Gabapentin Capsule IP | Each hard gelatin capsule contains: | ||||
Gabatentin | IP | 300 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Approved colour used in empty capsule shells | ||||||
165 | Loperamide Capsule IP | Each hard gelatin capsule contains: | ||||
Loperamide Hydrochloride | IP | 2 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Approved colour used in empty capsule shells | ||||||
166 | Pantoprazole & Domperidone SR Capsules | Each hard gelatin capsule contains: | ||||
Pantoparazole Sodium Sesquihydrate | IP | |||||
Eq. to Pantoprazole | 40 | mg | ||||
(As enteric coated Pellets) | ||||||
Domperidone | IP | 30 | mg | |||
(As Sustained release Pellets) | ||||||
Colour: Approved colour used empty capsule shell | ||||||
167 | Rabeprazole Sodium & Domperidone SR Capsules | Each hard gelatin capsule contains: | ||||
Rabeprazole Sodium | IP | 20 | mg | |||
(As enteric coated Pellets) | ||||||
Domperidone | IP | 30 | mg | |||
(As Sustained release Pellets) | ||||||
Colour: Approved colour used empty capsule shell | ||||||
168 | Rabeprazole Sodium & Levosulphride Capsules | Each hard gelatin capsule contains: | ||||
Rabeprazole Sodium | IP | 20 | mg | |||
(As enteric coated Pellets) | ||||||
Levosulphride | 75 | mg | ||||
(As Sustained release Pellets) | ||||||
Colour: Approved colour used empty capsule shell | ||||||
169 | Rabeprazole Sodium & Itopride Capsules | Each hard gelatin capsule contains: | ||||
Rabeprazole Sodium | IP | 20 | mg | |||
(As enteric coated Pellets) | ||||||
Itopride | 150 | mg | ||||
(As Sustained release Pellets) | ||||||
Colour: Approved colour used empty capsule shell | ||||||
170 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
Itraconazole Pellets Eq. to Itraconazole | 200 | mg | ||||
Colour: Approved colour used empty capsule shell | ||||||
171 | Omeprazole & Domperidone Capsules | Each hard gelatin capsule contains: | ||||
Omeprazole | IP | 20 | mg | |||
(As enteric coated Pellets) | ||||||
Domperidone | IP | 10 | mg | |||
(As Pellets) | ||||||
Colour: Approved colour used empty capsule shell | ||||||
172 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
Itraconazole Pellets Eq. to Itraconazole | 100 | mg | ||||
Colour: Approved colour used empty capsule shell | ||||||
173 | Esomeprazole Capsules | Each hard gelatin capsule contains: | ||||
Esomeprazole Magnesium | IP | |||||
Eq. to Esomeprazole | 40 | mg | ||||
(As enteric coated Pellets) | ||||||
Colour: Approved colour used empty capsule shell | ||||||
174 | Amoxycillin Trihydrate Capsules IP | Each hard gelatin capsule contains: | ||||
Amoxycillin Trihydrate | IP | |||||
eq. to Amoxycillin | 250 | mg | ||||
January 1, 1970 | Excipients | q.s. | ||||
Approved colour used in empty capsule shells | ||||||
175 | Amoxycillin Trihydrate Capsules IP | Each hard gelatin capsule contains: | ||||
Amoxycilline Trihydrate | IP | |||||
January 1, 1970 | eq. to Amoxycilline | 500 | mg | |||
Excipients | q.s. | |||||
Approved colour used in empty capsule shells | ||||||
176 | Amoxycillin & Dicloxacillin Sodium Capsules | Each hard gelatin capsule contains: | ||||
Amoxycillin Trihydrate | IP | |||||
eq. to Amoxycillin | 250 | mg | ||||
January 1, 1970 | Dicloxacillin Sodium | IP | ||||
eq. to Dicloxacillin | 250 | mg | ||||
Excipients | q.s. | |||||
Approved colour used in empty capsule shells | ||||||
177 | Ampicillin Trihydrate Capsules IP | Each hard gelatin capsule contains: | ||||
Ampicillin Trihydrate | IP | |||||
January 1, 1970 | eq. to Ampicillin | 250 | mg | |||
Excipients | q.s. | |||||
Approved colour used in empty capsule shells | ||||||
178 | Ampicillin Trihydrate Capsules IP | Each hard gelatin capsule contains: | ||||
Ampicillin Trihydrate | IP | |||||
eq. to Ampicillin | 500 | mg | ||||
January 1, 1970 | Excipients | q.s. | ||||
Approved colour used in empty capsule shells | ||||||
179 | Ampicillin & Dicloxacillin Sodium | Each hard gelatin capsule contains: | ||||
Capsules | Ampicillin Trihydrate | IP | ||||
eq. to Ampicillin | 250 | mg | ||||
Dicloxacillin Sodium | IP | |||||
January 1, 1970 | eq. to Dicloxacillin | 250 | mg | |||
Excipients | q.s. | |||||
Approved colour used in empty capsule shells | ||||||
180 | Cephalexin Capsules IP | Each hard gelatin capsule contains: | ||||
Cephalexin Monohydrate | IP | |||||
January 1, 1970 | eq. to Anhydrous Cephalexin | 500 | mg | |||
Excipients | q.s. | |||||
Approved colour used in empty capsule shells | ||||||
181 | Cephalexin Capsules IP | Each hard gelatin capsule contains: | ||||
Cephalexin Monohydrate | IP | |||||
January 1, 1970 | eq. to Anhydrous Cephalexin | 250 | mg | |||
Excipients | q.s. | |||||
Approved colour used in empty capsule shells | ||||||
182 | Pregabalin & Methylcobalamin Capsules | Each hard gelatin capsule contains: | ||||
Pregabalin | IP | 75 | mg | |||
Methylcobalamin | USP | 750 | mcg | |||
Excipients | q.s. | |||||
Approved colour used in empty capsule shells | ||||||
183 | Gabapentin & Methylcobalamin Capsules | Each hard gelatin capsule contains: | ||||
Gabapentin | IP | 300 | mg | |||
Methylcobalamin | USP | 500 | mcg | |||
Excipients | q.s. | |||||
Approved colour used in empty capsule shells | ||||||
184 | Amoxycillin For Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
January 1, 1970 | Amoxycillin Trihydrate | IP | ||||
January 1, 1970 | eq. to Amoxycillin | 125 | mg | |||
Excipients | q.s. | |||||
Colour: Sunset Yellow FCF & Tartrazine | ||||||
185 | Amoxycillin For Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
January 1, 1970 | Amoxycillin Trihydrate | IP | ||||
January 1, 1970 | eq. to Amoxycillin | 250 | mg | |||
Excipients | q.s. | |||||
Colour: Sunset Yellow FCF & Tartrazine | ||||||
186 | Cefpodoxime Proxetil Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
Cefpodoxime Proxetil | IP | |||||
January 1, 1970 | eq. to Cefpodoxime | 50 | mg | |||
Excipients | q.s. | |||||
Colour: Erythrosine | ||||||
January 1, 1970 | ||||||
187 | Cefpodoxime Proxetil Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
Cefpodoxime Proxetil | IP | |||||
January 1, 1970 | eq. to Cefpodoxime | 100 | mg | |||
Excipients | q.s. | |||||
January 1, 1970 | Colour: Erythrosine | |||||
188 | Cefixime Oral Suspension IP | Each5 ml reconstituted suspension contains: | ||||
Cefixime Trihydrate | IP | |||||
January 1, 1970 | eq. to Cefixime (Anhydrous) | 50 | mg | |||
January 1, 1970 | Excipients | q.s. | ||||
January 1, 1970 | Colour: Quinoline Yellow | |||||
January 1, 1970 | ||||||
189 | Cefixime Oral Suspension IP | Each5 ml reconstituted suspension contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Cefixime (Anhydrous) | 50 | mg | ||||
Excipients | q.s. | |||||
Colour: Sunset Yellow | ||||||
190 | Cefixime Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Anhydrous Cefixime | 100 | mg | ||||
Excipients | q.s. | |||||
Colour: Quinoline Yellow | ||||||
191 | Cefuroxime Axetil for Oral Suspension USP | Each 5 ml of reconstituted suspension contains: | ||||
Cefuroxime Axetil | IP | |||||
eq. to Cefuroxime | 125 | mg | ||||
Excipients | q.s. | |||||
Colour: Quinoline Yellow | ||||||
192 | Aceclofenac, Linseed Oil, Methyl | Composition: | ||||
Salicylate, Capsacin & Menthol Gel | Aceclofenac | IP | 0.015 | w/w | ||
Linseed Oil | BP | 0.03 | w/w | |||
Methyl Salicylate | IP | 0.1 | w/w | |||
Capsacin | BP | 0.00025 | w/w | |||
(eq. to pure capsaicin not less than 0.01375%w/w) | ||||||
Menthol | IP | 0.05 | w/w | |||
Benzyl Alcohol | IP | 0.01 | w/w | |||
(As Preservative) | ||||||
In a gel Base | ||||||
193 | Clindamycin Phosphate Gel USP | Composition: | ||||
Clindamycin Phosphate | IP | |||||
eq to Clindamycin | 0.01 | w/w | ||||
Gel Base | q.s. | |||||
194 | Clotrimazole Cream IP | Composition: | ||||
Clotrimazole | IP | 0.01 | w/w | |||
Cream Base | q.s. | |||||
195 | Diclofenac Diethylamine, Linseed | Composition: | ||||
Oil, Methyl Salicylate, Capsacin & | Diclofenac Diethylamine | BP | 0.0116 | w/w | ||
Menthol Gel | eq. to Diclofenac Sodium | 0.01 | w/w | |||
Linseed Oil | BP | 0.03 | w/w | |||
Methyl Salicylate | IP | 0.1 | w/w | |||
January 1, 1970 | Capsacin | IP | 0.0001 | w/w | ||
Menthol | IP | 0.05 | w/w | |||
Cream Base | q.s. | |||||
196 | Diclofenac Diethylamine, Linseed | Composition: | ||||
Oil, Methyl Salicylate & Menthol | Diclofenac Diethylamine | BP | 0.0116 | w/w | ||
Gel | eq. to Diclofenac Sodium | 0.01 | w/w | |||
Linseed Oil | BP | 0.03 | w/w | |||
Methyl Salicylate | IP | 0.1 | w/w | |||
Menthol | IP | 0.05 | w/w | |||
Benzyl Alcohol | IP | 0.01 | w/w | |||
(As Preservative) | ||||||
Gel Base | ||||||
197 | Diclofenac Diethylamine, Linseed | Composition: | ||||
Oil, Methyl Salicylate & Menthol | Diclofenac Diethylamine | BP | 0.0116 | w/w | ||
Gel | eq. to Diclofenac Sodium | 0.01 | w/w | |||
Linseed Oil | BP | 0.03 | w/w | |||
Methyl Salicylate | IP | 0.1 | w/w | |||
Menthol | IP | 0.005 | w/w | |||
Benzyl Alcohol | IP | 0.01 | w/w | |||
(As Preservative) | ||||||
Gel Base | ||||||
198 | Hydroxquinone, Tretinoin | Composition: | ||||
Hydrocortisone Cream | Hydroxquinone | USP | 0.02 | w/w | ||
Tretinoin | USP | 0.0005 | w/w | |||
Hydrocortisone | IP | 0.01 | w/w | |||
Cream Base | ||||||
199 | Miconazole Nitrate, Salicylic Acid, | Composition: | ||||
Sublimed Sulpher, Menthol & | Miconazole Nitrate | IP | 0.02 | w/w | ||
Camphor | Salicylic Acid | IP | 0.1 | w/w | ||
Sublimed Sulpher | IP | 0.05 | w/w | |||
January 1, 1970 | Menthol | IP | 0.01 | w/w | ||
Camphor | IP | 0.01 | w/w | |||
Ointment Base | q.s. | |||||
200 | Mometasone Furoate Cream IP | Composition: | ||||
Mometasone Furoate | IP | 0.001 | w/w | |||
Non aqueous Base | q.s. | |||||
201 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: | ||||
Ursodeoxycholic Acid | IP | 300 | mg | |||
Excipients | q.s. | |||||
Colours: Red Oxide of Iron & Titanium Dioxide IP | ||||||
202 | Aceclofenac, Paracetamol & Chlorzoxazone Tablets | Each filmcoated tablet contains: | ||||
Aceclofenac | IP | 100 | mg | |||
Paracetamol | IP | 325 | mg | |||
Chlorzoxazone | USP | 250 | mg | |||
Excipients | q.s | |||||
Colours: Quinoline Yellow | ||||||
203 | Clotrimazole Vaginal Tablets | Each uncoated vaginal tablet contains: | ||||
Clotrimazole | IP | 200 | mg | |||
Excipients | q.s | |||||
204 | Ketoconazole Tablets IP | Each uncoated tablet contains: | ||||
Ketoconazole | IP | 200 | mg | |||
Excipients | q.s. | |||||
205 | Etophylline & theophyllineTablets | Each uncoated tablet contains: | ||||
Etophylline | IP (85) | 77 | mg | |||
Theophylline (Anhydrous) | IP | |||||
January 1, 1970 | Eq. to Theophylline (Hydrate) | 23 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
206 | Paracetamol, Phenylepherine HCl & | Each uncoated tablet contains: | ||||
Levocetirizine HCl Tablets | Paracetamol | IP | 325 | mg | ||
January 1, 1970 | Phenylepherine Hydrochloride | IP | 5 | mg | ||
Levocetirizine Hydrochloride | IP | 5 | mg | |||
Excipients | q.s | |||||
Colour: Titanium Dioxide IP & Erythrosine | ||||||
207 | Levocetirizine HCl & Phenylepherine HCl Tablets | Each film coated tablet contains: | ||||
Levocetirizine Hydrochloride | IP | 5 | mg | |||
January 1, 1970 | Phenylepherine HCl | IP | 5 | mg | ||
Excipients | q.s | |||||
Colour: Titanium Dioxide IP | ||||||
208 | Drotaverine & Mefenamic Acid Tablets | Each filmcoated tablet contains: | ||||
Drotaverine Hydrochloride | IP | |||||
Eq. to Drotaverine | 80 | mg | ||||
Mefenamic Acid | IP | 250 | mg | |||
Excipients | q.s. | |||||
Colours: Indigo Caramine | ||||||
209 | Sucralfate & Oxetacaine Suspension | Each 10 ml contains: | ||||
Sucralfate | USP | 1 | gm | |||
Oxetacaine | BP | 10 | mg | |||
In a Flavoured palatable base | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
210 | Cyproheptadine & Tricholine | Each 5 ml contains: | ||||
Citrate Syrup | Cyproheptadine Hydrochloride | IP | 2 | mg | ||
Tricholine Citrate | 275 | mg | ||||
Flavoured Syrupy base | q.s | |||||
Colour: Caramel | ||||||
211 | Ambroxol HCl, Guaiphenesin, | Each 5 ml contains: | ||||
Terbutaline Sulphate & Menthol Syrup | Ambroxol HCl | IP | 15 | mg | ||
Guaiphenesin | IP | 50 | mg | |||
January 1, 1970 | Terbutaline Sulphate | IP | 1.25 | mg | ||
January 1, 1970 | Menthol | IP | 2.5 | mg | ||
Flavoured Syrupy base | q.s | |||||
Colour: Tartrazine | ||||||
212 | Ambroxol HCl, Guaiphenesin, | Each 5 ml contains: | ||||
Terbutaline Sulphate & Menthol | Ambroxol HCl | IP | 15 | mg | ||
Syrup | Guaiphenesin | IP | 50 | mg | ||
January 1, 1970 | Terbutaline Sulphate | IP | 1.25 | mg | ||
January 1, 1970 | Menthol | IP | 1 | mg | ||
Flavoured Syrupy base | q.s | |||||
Colour: Ponceau 4R | ||||||
213 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
Chlorpheniramine Maleate | Paracetamol | IP | 250 | mg | ||
Oral Suspension | Phenylephrine HCl | IP | 5 | mg | ||
Chlorpheniramine Maleate | IP | 2 | mg | |||
In Flavoured suspension base | ||||||
Colour: Ponceau 4R | ||||||
214 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
Chlorpheniramine Maleate | Paracetamol | IP | 125 | mg | ||
Oral Suspension | Phenylephrine HCl | IP | 2.5 | mg | ||
Chlorpheniramine Maleate | IP | 1 | mg | |||
In Flavoured suspension base | ||||||
Colour: Ponceau 4R | ||||||
215 | Potassium Citrate & Citric Acid | Each 5 ml contains: | ||||
Oral Solution | Potassium Citrate Monohydrate | IP | 1100 | mg | ||
Citric Acid Monohydrate | IP | 334 | mg | |||
In a Flavoured Syrupy base | q.s | |||||
Colour: Caramel | ||||||
216 | Aceclofenac, Paracetamol | Each film coated tablet contains: | ||||
& Serratiopeptidase tablets | Aceclofenac | IP | 100 | mg | ||
Paracetamol | IP | 325 | mg | |||
Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | |||
January 1, 1970 | Excipients | q.s. | ||||
Colour: Tartrazine & Titanium Dioxide IP | ||||||
217 | Aceclofenac, Paracetamol | Each film coated tablet contains: | ||||
& Serratiopeptidase tablets | Aceclofenac | IP | 100 | mg | ||
Paracetamol | IP | 325 | mg | |||
Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | |||
January 1, 1970 | Excipients | q.s. | ||||
Colour: Sunset Yellow & Titanium Dioxide IP | ||||||
218 | Cefixime Dispersible Tablets | Each uncoated dispersible tablet contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Anhydrous Cefixime | 50 | mg | ||||
Excipients | q.s. | |||||
219 | Amlodipine & Atenolol Tablets | Each uncoated tablet contains: | ||||
Amlodipine Besylate | IP | |||||
eq. to Amlodipine | 5 | mg | ||||
Atenolol | IP | 50 | mg | |||
Excipients | q.s. | |||||
220 | Ranitidine & Domperidone Tablets | Each film coated tablet contains: | ||||
Ranitidine Hydrochloride | IP | |||||
Eq. to Ranitidine | 150 | mg | ||||
January 1, 1970 | Domperidone | IP | 10 | mg | ||
Excipients | q.s | |||||
Colours: Tartrazine & Brilliant Blue | ||||||
221 | Diclofenac Potassium & | Each uncoated tablet contains: | ||||
Paracetamol tablets | Diclofenac Potassium | BP | 50 | mg | ||
January 1, 1970 | Paracetamol | IP | 325 | mg | ||
Excipients | q.s. | |||||
222 | Tranexamic Acid Tablets IP 500 mg | Each film coated tablet contains: | ||||
Tranexamic Acid | IP | 500 | mg | |||
Excipients | q.s. | |||||
Colours: Quinoline Yellow | ||||||
223 | Mefenamic Acid & Tranexamic Acid Tablets | Each film coated tablet contains: | ||||
Mefenamic Acid | IP | 250 | mg | |||
Tranexamic Acid | IP | 500 | mg | |||
Excipients | q.s. | |||||
Colours: Yellow Oxide of Iron & Titanium Dioxide IP | ||||||
224 | Paracetamol & Mefenamic Acid Tablets | Each uncoated tablet contains: | ||||
Paracetamol | IP | 325 | mg | |||
January 1, 1970 | Mefenamic Acid | IP | 250 | mg | ||
Excipients | q.s | |||||
225 | Paracetamol Suspension IP | Each 5 ml contains: | ||||
Paracetamol | IP | 125 | mg | |||
In Flavoured suspension base | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
226 | Paracetamol Suspension IP | Each 5 ml contains: | ||||
Paracetamol | IP | 250 | mg | |||
In Flavoured suspension base | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
227 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
Chlorpheniramine Maleate | Paracetamol | IP | 125 | mg | ||
Oral Suspension | Phenylephrine HCl | IP | 5 | mg | ||
Chlorpheniramine Maleate | IP | 1 | mg | |||
In Flavoured syrupy base | ||||||
Colour: Ponceau 4R | ||||||
228 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
Cetirizine Oral Suspension | Paracetamol | IP | 125 | mg | ||
Phenylephrine HCl | IP | 2.5 | mg | |||
Cetirizine | IP | 1 | mg | |||
In Flavoured syrupy base | ||||||
Colour: Carmoisine | ||||||
229 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
Cetirizine Oral Suspension | Paracetamol | IP | 125 | mg | ||
Phenylephrine HCl | IP | 5 | mg | |||
Cetirizine | IP | 2.5 | mg | |||
In Flavoured syrupy base | ||||||
Colour: Tartrazine | ||||||
230 | Cefpodoxime Proxetil Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
Cefpodoxime Proxetil | IP | |||||
January 1, 1970 | eq. to Cefpodoxime | 50 | mg | |||
Excipients | q.s. | |||||
Colour: Sunset Yellow | ||||||
231 | Chloramphenicol Capsules IP | Each hard gelatin capsule contains: | ||||
Chloramphenicol | IP | 250 | mg | |||
January 1, 1970 | Excipients | q.s. | ||||
Approved colour used in empty capsule shells | ||||||
232 | Chloramphenicol Capsules IP | Each hard gelatin capsule contains: | ||||
Chloramphenicol | IP | 500 | mg | |||
January 1, 1970 | Excipients | q.s. | ||||
Approved colour used in empty capsule shells | ||||||
233 | Lactulose Solution USP | Each 5 ml contains: | ||||
Lactulose | ||||||
(As Lactulose Concentrated) | USP | 3.35 | gm | |||
In a palatable base | q.s | |||||
234 | Methylcobalamin,Alpha Lipoic Acid, Folic Acid & Pyridoxine Hydrochloride Capsules | Each hard gelatin capsule contains: | ||||
Methylcobalamin | USP | 1500 | mcg | |||
( Sr. no. 603 26.09.2007 ) | Alpha Lipoic Acid | USP | 100 | mg | ||
Folic Acid | IP | 1.5 | mg | |||
Pyridoxine Hydrochloride | IP | 3 | mg | |||
Excipients | q.s. | |||||
Approved colour used in empty capsule shells | ||||||
235 | Oxetacaine, Aluminum Hydroxide & | Each 5 ml contains: | ||||
Magnesium Hydroxide Suspension | Oxetacaine | BP | 10 | mg | ||
Aluminum Hydroxide | 0.291 | gm | ||||
(As Dried Aluminium Hydroxide Gel IP 0.380 gm) | ||||||
January 1, 1970 | Magnesium Hydroxide | IP | 98 | mg | ||
Sorbital base | q.s | |||||
Colour: Erythrosine | ||||||
236 | Oxetacaine, Aluminum Hydroxide & | Each 5 ml contains: | ||||
Magnesium Hydroxide Suspension | Oxetacaine | BP | 10 | mg | ||
Aluminum Hydroxide | 0.291 | gm | ||||
(As Dried Aluminium Hydroxide Gel IP 0.380 gm) | ||||||
January 1, 1970 | Magnesium Hydroxide | IP | 98 | mg | ||
Sorbital base | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
237 | Nimesulide & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Nimesulide | BP | 100 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
Colour: Sunset Yellow FCF & Tartrazine | ||||||
238 | Nimesulide & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Nimesulide | BP | 100 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
Colour: Tartrazine & Fast Green | ||||||
239 | Deflazacort Tablets | Each uncoated tablet contains: | ||||
Deflazacort | 6 | mg | ||||
Excipients | q.s. | |||||
240 | Clotrimazole Vaginal Tablets IP | Each uncoated vaginal tablet contains: | ||||
Clotrimazole | IP | 100 | mg | |||
Excipients | q.s | |||||
241 | Sildenafil Citrate Tablets IP | Each Film-coated tablet contains: | ||||
Sildenafil Citrate | IP | |||||
equivalent to Sildenafil | 100 | mg | ||||
Excipients | q.s | |||||
Colours: Indigo carmine Lake & Titanium Dioxide IP | ||||||
242 | Sildenafil Citrate Tablets IP | Each Film-coated tablet contains: | ||||
Sildenafil Citrate | IP | |||||
equivalent to Sildenafil | 100 | mg | ||||
Excipients | q.s | |||||
Colours: Titanium Dioxide IP, Iron Oxide Red, Lake of Indigo carmine & Lake of Ponceau 4R | ||||||
243 | Sildenafil Citrate Tablets IP | Each Film-coated tablet contains: | ||||
Sildenafil Citrate | IP | |||||
equivalent to Sildenafil | 50 | mg | ||||
Excipients | q.s | |||||
Colours: Titanium Dioxide IP, Iron Oxide Red, Lake of Indigo carmine & Lake of Ponceau 4R | ||||||
244 | Pyrazinamide Tablets IP | Each uncoated tablet contains: | ||||
Pyrazinamide | IP | 500 | mg | |||
Excipients | q.s. | |||||
245 | Etamsylate Tablets | Each uncoated tablet contains: | ||||
January 1, 1970 | Etamsylate | BP | 250 | mg | ||
Excipients | q.s | |||||
246 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
Itraconazole Pellets Eq. to Itraconazole | BP | 100 | mg | |||
Colour: Approved colour used empty capsule shell | ||||||
247 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
Itraconazole Pellets Eq. to Itraconazole | BP | 200 | mg | |||
Colour: Approved colour used empty capsule shell | ||||||
248 | Ondensetron Oral Solution IP | Each 5 ml contains: | ||||
Ondansetron HCl | IP | |||||
eq. to Ondansetron | 2 | mg | ||||
Flavoured Syrupy base | q.s | |||||
Colour: Ponceau 4R | ||||||
249 | Diphenhydramine Hydrochloride, | Each 5 ml contains: | ||||
Ammonium Chloride, Sodium Citrate & | Diphenhydramine Hydrochloride | IP | 14.08 | mg | ||
Menthol Syrup | Ammonium Chloride | IP | 138 | mg | ||
Sodium Citrate | IP | 57.03 | mg | |||
Menthol | IP | 1.14 | mg | |||
In Flavoured syrupy base | q.s. | |||||
Colour: Ponceau 4R | ||||||
250 | Povidone-Iodine Ointment USP | Composition: | ||||
Povidone-Iodine | IP | 0.05 | w/w | |||
(available Iodine 0.5% w/w) | ||||||
Water Soluble Ointment base | q.s. | |||||
251 | Mupirocin Ointment IP | Composition: | ||||
Mupirocin | IP | 0.02 | w/w | |||
In a non Greasy base | q.s. | |||||
252 | Terbinafine Hydrochloride Cream | Composition: | ||||
Terbinafine Hydrochloride | BP | 0.01 | w/w | |||
Benzyl Alcohol | IP | 0.01 | w/w | |||
(as preservative) | ||||||
In a cream base | ||||||
253 | Clotrimazole Vaginal Gel | Composition: | ||||
Clotrimazole | IP | 0.02 | w/w | |||
preservatives: | ||||||
Benzyl Alcohol | IP | 0.02 | w/w | |||
Chlorocresol | IP | 0.001 | w/w | |||
Cream Base | q.s. | |||||
254 | Gamma Benzene Hexachloride & Cetrimide Lotion | Composition: | ||||
Gamma Benzene Hexachloride | IP | 0.01 | w/v | |||
Cetrimide | IP | 0.001 | w/v | |||
In an emulsion base | q.s | |||||
255 | Gamma Benzene Hexachloride Lotion | Composition: | ||||
Gamma Benzene Hexachloride | IP | 0.01 | w/v | |||
In an emulsion base | q.s | |||||
256 | Paracetamol, Diclofenac Sodium | Each film coated tablet contains: | ||||
& Serratiopeptidase tablets | Paracetamol | IP | 325 | mg | ||
Diclofenac Sodium | IP | 50 | mg | |||
January 1, 1970 | Serratiopeptidase (30,000 units of Serratiopeptidase as enteric coated granules) | IP | 15 | mg | ||
Excipients | q.s. | |||||
Colour: Sunset Yellow & Titanium Dioxide IP | ||||||
257 | Paracetamol, Diclofenac Sodium | Each film coated tablet contains: | ||||
& Serratiopeptidase tablets | Paracetamol | IP | 325 | mg | ||
Diclofenac Sodium | IP | 50 | mg | |||
January 1, 1970 | Serratiopeptidase (20,000 units of Serratiopeptidase as enteric coated granules) | IP | 10 | mg | ||
Excipients | q.s. | |||||
Colour: Sunset Yellow & Titanium Dioxide IP | ||||||
258 | Clobetasol Propionate Cream IP | Composition: | ||||
Clobetasol Propionate | IP | 0.0005 | w/w | |||
IP-2014 Page no.1424 | Chlorocresol | IP | 0.001 | w/w | ||
(as preservative) | ||||||
In a non-greasy base | q.s. | |||||
259 | Clobetasol Propionate & | Composition: | ||||
Miconazole Nitrate Cream | Clobetasol Propionate | IP | 0.0005 | w/w | ||
Miconazole Nitrate | IP | 0.02 | w/w | |||
Cream Base | q.s. | |||||
260 | Clobetasol Propionate & | Composition: | ||||
Neomycin Sulphate Cream | Clobetasol Propionate | IP | 0.0005 | w/w | ||
Neomycin Sulphate | IP | |||||
eq. to Neomycin | 0.005 | w/w | ||||
Cream Base | q.s. | |||||
261 | Beclomethasone Dipropionate & | Composition: | ||||
Clotrimazole Cream | Beclomethasone Dipropionate | IP | 0.00025 | w/w | ||
Clotrimazole | IP | 0.01 | w/w | |||
Cream base | q.s. | |||||
262 | Mometasone Furoate Cream IP | Composition: | ||||
IP-2014 Page no.2245 | Mometasone Furoate | IP | 0.001 | w/w | ||
In Cream base | q.s. | |||||
263 | Mometasone Furoate & Nadifloxacin | Composition: | ||||
Cream | Mometasone Furoate | IP | 0.001 | w/w | ||
565 Dated 17.08.2006 | Nadifloxacin | 0.01 | w/w | |||
In Cream base | q.s. | |||||
264 | Paracetamol, Phenylephrine HCl & | Each 5 ml contains: | ||||
Chlorpheniramine Maleate | Paracetamol | IP | 250 | mg | ||
Oral Suspension | Phenylephrine HCl | IP | 5 | mg | ||
Chlorpheniramine Maleate | IP | 1 | mg | |||
In Flavoured suspension base | q.s. | |||||
Colour: Ponceau 4R | ||||||
265 | Paracetamol, Phenylephrine Hydrochloride | Each ml contains: | ||||
& Chlorpheniramine Maleate Drops | Paracetamol | IP | 125 | mg | ||
Phenylephrine HCl | IP | 2.5 | mg | |||
Chlorpheniramine Maleate | IP | 1 | mg | |||
In Flavoured syrup base | q.s. | |||||
Colour: Ponceau 4R | ||||||
266 | Paracetamol Oral Suspension IP | Each ml contains: | ||||
Paracetamol | IP | 100 | mg | |||
In Flavoured syrup base | q.s. | |||||
Colour: Ponceau 4R | ||||||
267 | Aceclofenac & Paracetamol Tablets | Each uncoated tablet contains: | ||||
Aceclofenac | IP | 100 | mg | |||
Paracetamol | IP | 325 | mg | |||
January 1, 1970 | Excipients | q.s | ||||
Colours: Carmoisine & Tartrazine | ||||||
268 | Carbonyl Iron, Zinc Sulphate & | Each hard gelatin capsule contains: | ||||
Folic Acid Capsule | Carbonyl Iron | |||||
eq. to Elemental Iron | 50 | mg | ||||
Zinc Sulphate Monohydrate | IP | 61.8 | mg | |||
(eq. to Elemental Zinc 22.5mg) | ||||||
Folic Acid | IP | 0.5 | mg | |||
Approved colour used in empty capsule shells | ||||||
269 | Doxylamine Succinate & Pyridoxine Hydrochloride | Each enteric coated tablet contains: | ||||
Gastro-Resistant Tablets | Doxylamine Succinate | USP | 10 | mg | ||
Pyridoxine Hydrochloride | IP | 10 | mg | |||
Excipients | q.s. | |||||
Colour: Ponceau 4R & Titanium Dioxide IP | ||||||
270 | Luliconazole Cream 1.0% w/w | Composition: | ||||
Luliconazole | 0.01 | w/w | ||||
In Cream base | q.s. | |||||
271 | Diphenhydramine Hydrochloride, | Each 5 ml contains: | ||||
Ammonium Chloride & Sodium Citrate | Diphenhydramine Hydrochloride | IP | 14.08 | mg | ||
Syrup | Ammonium Chloride | IP | 138 | mg | ||
Sodium Citrate | IP | 57.03 | mg | |||
In Mantholated syrupy base | q.s. | |||||
Colour: Cramoisine, Sunset Yellow FCF, Erythrosine & Caramel | ||||||
272 | Mefenamic Acid Suspension | Each 5 ml contains: | ||||
Mefenamic Acid | IP | 100 | mg | |||
In Flavoured syrup base | q.s. | |||||
Colour: Sunset Yellow FCF | ||||||
273 | Levocetirizine Dihydrochloride Syrup | Each 5 ml contains: | ||||
Levocetirizine Dihydrochloride | IP | 2.5 | mg | |||
In a Flavoured Syrupy base | q.s | |||||
Colour: Quinoline Yellow WS | ||||||
274 | Cetirizine Syrup IP | Each 5 ml contains: | ||||
Cetirizine Hydrochloride | IP | 5 | mg | |||
In a Flavoured Syrupy base | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
275 | Fexofenadine Hydrochloride Oral Suspension | Each 5 ml contains: | ||||
Fexofenadine Hydrochloride | IP | 30 | mg | |||
In a Flavoured Syrupy base | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
276 | Fexofenadine Hydrochloride & Montelukast | Each 5 ml contains: | ||||
Sodium Suspension | Fexofenadine Hydrochloride | IP | 60 | mg | ||
Montelukast Sodium | IP | |||||
eq. to Montelukast | 2 | mg | ||||
In a Flavoured Syrupy base | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
277 | Ketoconazole Tablets IP | Each uncoated tablet contains: | ||||
Ketoconazole | IP | 200 | mg | |||
Excipients | q.s. | |||||
Colour: Sunset Yellow FCF | ||||||
278 | Fluconazole & Ivermectin Tablets | Each uncoated tablet contains: | ||||
Fluconazole | IP | 150 | mg | |||
Ivermectin | IP | 6 | mg | |||
Excipients | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
279 | Itraconazole Gel | Composition: | ||||
Itraconazole | BP | 0.01 | w/w | |||
In a Gel base | qs | |||||
280 | Luliconazole Dusting Powder | Composition: | ||||
Luliconazole | 0.01 | w/w | ||||
Talcum I.P. Base | q.s. | |||||
281 | Itraconazole Dusting Powder | Composition: | ||||
Itraconazole | BP | 0.01 | w/w | |||
Talcum I.P. Base | q.s. | |||||
282 | Clotremazole Dusting Powder | Composition: | ||||
Clotremazole | IP | 0.01 | w/w | |||
Talcum I.P. Base | q.s. | |||||
283 | Miconazole Nitrate Dusting Powder | Composition: | ||||
Miconazole Nitrate | IP | 0.02 | w/w | |||
Talcum I.P. Base | q.s. | |||||
284 | Artemether & Lumefantrine Dry Syrup | Each 5 ml of reconstituted suspension contains: | ||||
Artemether | IP | 40 | mg | |||
January 1, 1970 | Lumefantrine | 240 | mg | |||
Excipients | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
285 | Azithromycin Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
Azithromycin | IP | 100 | mg | |||
Excipients | q.s | |||||
Colour: Erythrosine | ||||||
286 | Azithromycin Oral Suspension IP | Each 5 ml of reconstituted suspension contains: | ||||
Azithromycin | IP | 200 | mg | |||
Excipients | q.s | |||||
Colour: Sunset Yellow FCF | ||||||
287 | Itraconazole Sustained Release Tablets 400 mg | Each Film Coated Sustained Release tablet contains: | ||||
Itraconazole | BP | 400 | mg | |||
Excipients | q.s. | |||||
Colour: Titanium Dioxide IP | ||||||
288 | Ketorolac Tromethamine Tablets IP | Each uncoated tablet contains: | ||||
Ketorolac Tromethamine | IP | 10 | mg | |||
Excipients | q.s. | |||||
289 | Tamsulotion Hydrochloride Modified Release | Each hard gelatin capsule contains: | ||||
Capsule | Tamsulotion Hydrochloride | IP | 400 | mcg | ||
(As Modified Release Pellets) | ||||||
Excipients | q.s. | |||||
Approved colour used in empty capsule shells | ||||||
290 | Cefpodoxime Proxetil Dispersible | Each uncoated dispersible tablet contains: | ||||
Tablets | Cefpodoxime Proxetil | IP | ||||
eq. to Cefpodoxime | 50 | mg | ||||
Excipients | q.s. | |||||
291 | Metformin Hydrochloride Tablets IP | Each uncoated tablet contains: | ||||
Metformin Hydrochloride | IP | 500 | mg | |||
Excipients | q.s | |||||
292 | Calcium with vitamin D3 Tablets IP | Each film coated tablet contains: | ||||
1.25 g Calcium carbonate from an organic | ||||||
source (Oyster Shell) | ||||||
Eq. to elemental calcium | 500 | mg | ||||
Vitamin D3 | IP | 250 | IU | |||
Colour: Brilliant Blue FCF & Titanium Dioxide IP | ||||||
293 | Diclofenac Sodium & Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
Diclofenac Sodium | IP | 50 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
294 | Diclofenac Sodium & Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
Diclofenac Sodium | IP | 50 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
Colour: Quinoline Yellow | ||||||
295 | Diclofenac Sodium & Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
Diclofenac Sodium | IP | 50 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
Colours: Tartrazine & Fast Green | ||||||
296 | Ofloxacin & Ornidazole Tablets IP | Each film coated tablet contains: | ||||
Ofloxacin | IP | 200 | mg | |||
Ornidazole | IP | 500 | mg | |||
Excipients | q.s | |||||
Colours: Sunset Yellow FCF, Tartrazine & Titanium Dioxide IP | ||||||
297 | Dicyclomine Hydrochloride & Mefenamic Acid Tablets IP | Each uncoated tablet contains: | ||||
Dicyclomine Hydrochloride | IP | 10 | mg | |||
Mefenamic Acid | IP | 250 | mg | |||
Excipients | q.s | |||||
Colour: Tartrazine | ||||||
298 | Ibuprofen & Paracetamol Tablets IP | Each uncoated tablet contains: | ||||
Ibuprofen | IP | 400 | mg | |||
Paracetamol | IP | 325 | mg | |||
Excipients | q.s | |||||
299 | Montelukast Sodium & Levocetirizine HCl Tablets | Each film coated tablet contains: | ||||
IP | Montelukast Sodium | IP | ||||
Eq. to Montelukast | 10 | mg | ||||
January 1, 1970 | Levocetirizine Di Hydrochloride | IP | 5 | mg | ||
Excipients | q.s | |||||
Colours: Quinoline Yellow & Titanium Dioxide IP | ||||||
300 | Terbinafine Hydrochloride Tablets IP | Each uncoated tablet contains: | ||||
Terbinafine Hydrochloride | IP | |||||
eq. to Terbinafine | 250 | mg | ||||
Excipients | q.s | |||||
301 | Paracetamol & Caffeine Tablets IP | Each uncoated tablet contains: | ||||
Paracetamol | IP | 325 | mg | |||
January 1, 1970 | Caffeine | IP | 30 | mg | ||
Excipients | q.s | |||||
Colour: Red Oxide of Iron | ||||||
302 | Cefixime Dispersible Tablets IP | Each uncoated dispersible tablet contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Anhydrous Cefixime | 50 | mg | ||||
Excipients | q.s. | |||||
303 | Cefixime Dispersible Tablets IP | Each uncoated dispersible tablet contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Anhydrous Cefixime | 100 | mg | ||||
Excipients | q.s. | |||||
304 | Cefixime Dispersible Tablets IP | Each uncoated dispersible tablet contains: | ||||
Cefixime Trihydrate | IP | |||||
eq. to Anhydrous Cefixime | 200 | mg | ||||
Excipients | q.s. | |||||
305 | Pantoprazole Gesto-resistant & Domperidone Prolonged-release Capsules IP | Each hard gelatin capsule contains: | ||||
Pantoparazole Sodium Sesquihydrate | IP | |||||
Eq. to Pantoprazole | 40 | mg | ||||
(As enteric coated Pellets) | ||||||
Domperidone | IP | 30 | mg | |||
(As Sustained release Pellets) | ||||||
Colour: Approved colour used empty capsule shell | ||||||
306 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
Itraconazole Pellets | ||||||
Eq. to Itraconazole | BP | 100 | mg | |||
Excipients | qs | |||||
Colour: Titanium Dioxide IP, Brilliant Bule FCF & Tartrazine colours used in empty capsule shells. | ||||||
307 | Itraconazole Capsules | Each hard gelatin capsule contains: | ||||
Itraconazole Pellets | ||||||
Eq. to Itraconazole | BP | 200 | mg | |||
Excipients | qs | |||||
Colour: Titanium Dioxide IP, Sunset Yellow FCF, Ponceau-4R & Carmoisine colours used in empty capsule shells. | ||||||
308 | Thiocolchicoside & Aceclofenac Tablets | Each film coated contains: | ||||
Thiocolchicoside | IP | 4 | mg | |||
Aceclofenac | IP | 100 | mg | |||
Excipients | qs | |||||
Colours: Quinoline yellow & Titanium Dioxide IP | ||||||
309 | Etoricoxib & Thiocolchicoside Tablets | Each film coated contains: | ||||
Etoricoxib | IP | 60 | mg | |||
Thiocolchicoside | IP | 4 | mg | |||
Excipients | qs | |||||
Colours: Tartrazine | ||||||
310 | Arterolane Maleate & Piperaquine | Each film coated contains: | ||||
Phosphate Tablets | Arterolane Maleate | IP | ||||
eq. to Arterolane | 150 | mg | ||||
Piperaquine Phosphate | 750 | mg | ||||
Excipients | qs | |||||
Colours: Yellow oxide of iron, Red oxide of iron & Titanium Dioxide IP | ||||||
311 | Losartan Potassium Tablets IP | Each uncoated Tablet contains: | ||||
Losartan Potassium | IP | 25 | mg | |||
Excipients | qs | |||||
Colour: Titanium Dioxide I.P. | ||||||
312 | Losartan Potassium Tablets IP | Each uncoated Tablet contains: | ||||
Losartan Potassium | IP | 50 | mg | |||
Excipients | qs | |||||
Colour: Titanium Dioxide I.P. | ||||||
313 | Losartan Potassium Tablets IP | Each Film coated Tablet contains: | ||||
Losartan Potassium | IP | 25 | mg | |||
Excipients | qs | |||||
Colour: Approved Colour Used | ||||||
314 | Losartan Potassium Tablets IP | Each film coated Tablet contains: | ||||
Losartan Potassium | IP | 50 | mg | |||
Excipients | qs | |||||
Colour: Approved Colour Used | ||||||
315 | Terbinafine Hydrochloride Tablets IP | Each uncoated tablet contains: | ||||
Terbinafine Hydrochloride | IP | |||||
eq. to Terbinafine | 500 | mg | ||||
Excipients | q.s | |||||
316 | Ursodeoxycholic Acid Tablets IP | Each film coated tablet contains: | ||||
Page No. 3466 (IP2018) | Ursodeoxycholic Acid | IP | 300 | mg | ||
Excipients | q.s. | |||||
Colour: Titanium Dioxide IP | ||||||
317 | Atorvastatin & Aspirin Capsules | Each hard gelatin capsule contains: | ||||
Atorvastatin Calcium | IP | |||||
S. No.-771 DCGI 18/01/2008 | Eq. to Atorvastatin | 10 | mg | |||
(as immediate release pellets) | ||||||
Aspirin | IP | 75 | mg | |||
(As enteric coated pellets) | ||||||
Excipients | qs | |||||
Approved colours used in empty capsule shells and pellets. | ||||||
318 | Atorvastatin & Aspirin Capsules | Each hard gelatin capsule contains: | ||||
Atorvastatin Calcium | IP | |||||
S. No.-771 DCGI 18/01/2008 | Eq. to Atorvastatin | 10 | mg | |||
(as immediate release pellets) | ||||||
Aspirin | IP | 150 | mg | |||
(As enteric coated pellets) | ||||||
Excipients | qs | |||||
Approved colours used in empty capsule shells and pellets. | ||||||
319 | Amlodipine & Atorvastatin Tablets | Each film coated tablet contains: | ||||
Amlodipine Besylate | IP | |||||
S. No.- 414 DCGI-11/02/2004 | eq. to Amlodipine | 5 | mg | |||
Atorvastatin Calcium | IP | |||||
Eq. to Atorvastatin | 10 | mg | ||||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
320 | Amlodipine & Atorvastatin Tablets | Each uncoated tablet contains: | ||||
Amlodipine Besylate | IP | |||||
S. No.- 431 DCGI-20/10/2004 | eq. to Amlodipine | 5 | mg | |||
Atorvastatin Calcium | IP | |||||
Eq. to Atorvastatin | 20 | mg | ||||
Excipients | q.s. | |||||
321 | Amlodipine & Atorvastatin Tablets | Each uncoated tablet contains: | ||||
Amlodipine Besylate | IP | |||||
S. No.- 431 DCGI-20/10/2004 | eq. to Amlodipine | 5 | mg | |||
Atorvastatin Calcium | IP | |||||
Eq. to Atorvastatin | 40 | mg | ||||
Excipients | q.s. | |||||
322 | Amlodipine & Atorvastatin Tablets | Each uncoated tablet contains: | 28.25 | |||
Amlodipine Besylate | IP | |||||
S. No.- 431 DCGI-20/10/2004 | eq. to Amlodipine | 10 | mg | |||
Atorvastatin Calcium | IP | |||||
Eq. to Atorvastatin | 10 | mg | ||||
Excipients | q.s. | |||||
323 | Amlodipine & Atorvastatin Tablets | Each uncoated tablet contains: | 2.3958333333333 | |||
Amlodipine Besylate | IP | |||||
S. No.- 431 DCGI-20/10/2004 | eq. to Amlodipine | 10 | mg | |||
Atorvastatin Calcium | IP | |||||
Eq. to Atorvastatin | 20 | mg | ||||
Excipients | q.s. | |||||
324 | Amlodipine & Atorvastatin Tablets | Each uncoated tablet contains: | 24.001736111111 | |||
Amlodipine Besylate | IP | |||||
S. No.- 431 DCGI-20/10/2004 | eq. to Amlodipine | 10 | mg | |||
Atorvastatin Calcium | IP | |||||
Eq. to Atorvastatin | 40 | mg | ||||
Excipients | q.s. | |||||
325 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 434 DCGI-08/11/2004 | Eq. to Atorvastatin | 10 | mg | |||
Ezetimibe | IP | 10 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
326 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 434 DCGI-08/11/2004 | Eq. to Atorvastatin | 20 | mg | |||
Ezetimibe | IP | 10 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
327 | Atorvastatin & Ezetimibe Tablets | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 663 DCGI-30/07/2007 | Eq. to Atorvastatin | 40 | mg | |||
Ezetimibe | IP | 10 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
328 | Atorvastatin & Metoprolol Succinate (ER) | Each uncoated bilayer tablet contains: | 24.001736111111 | |||
Tablets | Atorvastatin Calcium | IP | ||||
S. No.- 791 DCGI-28/01/2008 | Eq. to Atorvastatin | 10 | mg | |||
Metoprolol Succinate | IP | 47.5 | mg | |||
eq. to Metoprolol Tartrate | 50 | mg | ||||
(As Extended Release Form) | ||||||
Excipients | q.s. | |||||
Colours: Approved Colour used | ||||||
329 | Atorvastatin & Metoprolol Succinate (ER) | Each uncoated bilayer tablet contains: | 24.001736111111 | |||
Tablets | Atorvastatin Calcium | IP | ||||
S. No.- 791 DCGI-28/01/2008 | Eq. to Atorvastatin | 10 | mg | |||
Metoprolol Succinate | IP | 23.75 | mg | |||
eq. to Metoprolol Tartrate | 25 | mg | ||||
(As Extended Release Form) | ||||||
Excipients | q.s. | |||||
Colours: Approved Colour used | ||||||
330 | Atorvastatin & Telmisartan Tablets | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 747 DCGI-22/05/2008 | Eq. to Atorvastatin | 10 | mg | |||
Telmisartan | IP | 40 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
331 | Atorvastatin & Metformin HCl (SR) | Each uncoated tablet contains: | 24.001736111111 | |||
Tablets | Atorvastatin Calcium | IP | ||||
Eq. to Atorvastatin | 10 | mg | ||||
S. No.- 878 DCGI-04/12/2008 | Metformin Hydrochloride | IP | 500 | mg | ||
(As Sustained Release Form) | ||||||
Excipients | q.s. | |||||
Colours: Approved Colour used | ||||||
332 | Atorvastatin, Glimepiride & Metformin | Each uncoated tablet contains: | 24.001736111111 | |||
HCl (SR) Tablets | Atorvastatin Calcium | IP | ||||
Eq. to Atorvastatin | 10 | mg | ||||
S. No.- 957 DCGI-17/12/2009 | Glimepiride | IP | 1 | mg | ||
Metformin Hydrochloride | IP | 500 | mg | |||
(As Extended Release Form) | ||||||
Excipients | q.s. | |||||
Colours: Approved Colour used | ||||||
333 | Atorvastatin, Glimepiride & Metformin | Each uncoated tablet contains: | 24.001736111111 | |||
HCl (SR) Tablets | Atorvastatin Calcium | IP | ||||
Eq. to Atorvastatin | 10 | mg | ||||
S. No.- 957 DCGI-17/12/2009 | Glimepiride | IP | 2 | mg | ||
Metformin Hydrochloride | IP | 500 | mg | |||
(As Sustained Release Form) | ||||||
Excipients | q.s. | |||||
Colours: Approved Colour used | ||||||
334 | Atorvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 776 DCGI-25/01/2008 | Eq. to Atorvastatin | 10 | mg | |||
Fenofibrate | IP | 80 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
335 | Atorvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 438 DCGI-24/12/2004 | Eq. to Atorvastatin | 10 | mg | |||
Fenofibrate | IP | 160 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
336 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
Tablets | Atorvastatin Calcium | IP | ||||
Eq. to Atorvastatin | 5 | mg | ||||
S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 20 | mg | ||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
337 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
Tablets | Atorvastatin Calcium | IP | ||||
Eq. to Atorvastatin | 10 | mg | ||||
S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 20 | mg | ||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
338 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
Tablets | Atorvastatin Calcium | IP | ||||
Eq. to Atorvastatin | 20 | mg | ||||
S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 20 | mg | ||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
339 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
Tablets | Atorvastatin Calcium | IP | ||||
Eq. to Atorvastatin | 5 | mg | ||||
S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 40 | mg | ||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
340 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
Tablets | Atorvastatin Calcium | IP | ||||
Eq. to Atorvastatin | 10 | mg | ||||
S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 40 | mg | ||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
341 | Atorvastatin & Olmesartan Medoxomil | Each film coated tablet contains: | 24.001736111111 | |||
Tablets | Atorvastatin Calcium | IP | ||||
Eq. to Atorvastatin | 20 | mg | ||||
S. No.- 946 DCGI-27/10/2009 | Olmesartan Medoxomil | IP | 40 | mg | ||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
342 | Atorvastatin & Ramipril Tablets | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 680 DCGI-15/10/2007 | Eq. to Atorvastatin | 10 | mg | |||
Ramipril | IP | 2.5 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
343 | Atorvastatin & Ramipril Tablets | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 680 DCGI-15/10/2007 | Eq. to Atorvastatin | 10 | mg | |||
Ramipril | IP | 5 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
344 | Atorvastatin & Ramipril Tablets | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 1002 DCGI-17/03/2010 | Eq. to Atorvastatin | 20 | mg | |||
Ramipril | IP | 2.5 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
345 | Atorvastatin & Ramipril Tablets | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 1002 DCGI-17/03/2010 | Eq. to Atorvastatin | 20 | mg | |||
Ramipril | IP | 5 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
346 | Atorvastatin Tablets IP | Each film coated tablet contains: | -87.994791666667 | |||
Atorvastatin Calcium | IP | |||||
Page No.- 1287 IP-2018 | Eq. to Atorvastatin | 20 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
347 | Atorvastatin Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
Page No.- 1287 IP-2018 | Eq. to Atorvastatin | 40 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
348 | Atorvastatin Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
Page No.- 1287 IP-2018 | Eq. to Atorvastatin | 80 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
349 | Rosuvastatin Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
Rosuvastatin Calcium | IP | |||||
Page No.- 3142 IP-2018 | Eq. to Rosuvastatin | 40 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
350 | Rosuvastatin Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
Rosuvastatin Calcium | IP | |||||
Page No.- 3142 IP-2018 | Eq. to Rosuvastatin | 80 | mg | |||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
351 | Rosuvastatin & Aspirin Capsules | Each hard gelatin capsule contains: | ||||
Rosuvastatin Calcium | IP | |||||
Eq. to Rosuvastatin | 10 | mg | ||||
S. No.- 1101 DCGI-30/03/2011 | (As film coated pellets) | |||||
Aspirin | IP | 150 | mg | |||
(As enteric coated pellets) | ||||||
Excipients | q.s. | |||||
Approved colours used in empty capsule shells and pellets. | ||||||
352 | Aspirin & Clopidogrel Capsules | Each uncoated tablet contains: | 24.001736111111 | |||
Aspirin | IP | 75 | mg | |||
(As enteric coated pellets) | ||||||
S. No.- 365 DCGI-27/11/2002 | Clopidogrel Bisulphate | IP | ||||
eq. to Clopidogrel | 75 | mg | ||||
(As immediate release pellets) | ||||||
Excipients | q.s. | |||||
Approved colours used in empty capsule shells and pellets. | ||||||
353 | Atorvastatin & Fenofibrate Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
Atorvastatin Calcium | IP | |||||
S. No.- 487 DCGI-30/10/2007 | Eq. to Atorvastatin | 10 | mg | |||
Page No.- 1289 IP-2018 | Fenofibrate | IP | 145 | mg | ||
Excipients | q.s. | |||||
Colours: Approved Colour used in coating | ||||||
354 | Ofloxacin Tablets IP | Each film coated tablet contains: | 24.001736111111 | |||
Ofloxacin | IP | 400 | mg | |||
Page No.- 2769 IP-2018 | Excipients | q.s. | ||||
Colour: Titanium Dioxide IP | ||||||
355 | Promethazine Hydrochloride Tablets IP | Each uncoated tablet contains: | 24.001736111111 | |||
Page No.- 3016 IP-2018 | Promethazine Hydrochloride | IP | 25 | mg | ||
Excipients | q.s. | |||||
356 | Gliclazide Tablets IP | Each Uncoated Tablet Contains: | ||||
Gliclazide | I.P. | 80 mg | ||||
Excipients | QS | |||||
357 | Glimepiride Tablets IP | Each Uncoated Tablet Contains: | ||||
Glimepiride | I.P. | 1 mg | ||||
Excipients | QS | |||||
358 | Glimepiride Tablets IP | Each Uncoated Tablet Contains: | ||||
Glimepiride | I.P. | 2 mg | ||||
Excipients | QS | |||||
359 | Voglibose and Metformin HCl (Extended Release) Tablets | Each uncoated Bilayered tablet contains | ||||
Voglibose | I.P. | 0.3 mg | ||||
Metformin Hydrochloride | I.P. | 500 mg | ||||
(As Extended Release) | ||||||
Excipients | QS | |||||
Approved colour used. | ||||||
360 | Amlodipine and Clopidogrel Tablets | Each Film coated Tablet contains | ||||
Amlodipine Besylate | I.P. | |||||
Eq. To Amlodipine | 5 mg | |||||
Clopidogrel Bisulphate | I.P. | |||||
Eq. to Clopidogrel | 75 mg | |||||
Excipients | QS | |||||
Approved colour used. | ||||||
361 | Clopidogrel and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
Aspirin | I.P. | 100 mg | ||||
As Enteric Coated Pellets | ||||||
Clopidogrel Bisulphate | I.P. | |||||
Eq. to Clopidogrel | 75 mg | |||||
As Pellets | ||||||
Excipients | QS | |||||
Approved colour used. | ||||||
362 | Clopidogrel and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
Aspirin | I.P. | 75 mg | ||||
As Enteric Coated Pellets | ||||||
Clopidogrel Bisulphate | I.P. | |||||
Eq. to Clopidogrel | 150 mg | |||||
As Pellets | ||||||
Excipients | QS | |||||
Approved colour used. | ||||||
363 | Clopidogrel and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
Aspirin | I.P. | 150 mg | ||||
As Enteric Coated Pellets | ||||||
Clopidogrel Bisulphate | I.P. | |||||
Eq. to Clopidogrel | 300 mg | |||||
As Pellets | ||||||
Excipients | QS | |||||
Approved colour used. | ||||||
364 | Rosuvastatin and Fenofibrate Tablets | Each film coated tablet contains | ||||
Rosuvastatin Calcium | I.P. | |||||
Eq. to Rosuvastatin | 5 mg | |||||
Finofibrate | I.P. | 67 mg | ||||
Excipients | QS | |||||
Approved colour used. | ||||||
365 | Rosuvastatin and Fenofibrate Tablets | Each film coated tablet contains | ||||
Rosuvastatin Calcium | I.P. | |||||
Eq. to Rosuvastatin | 10 mg | |||||
Finofibrate | I.P. | 145 mg | ||||
Excipients | QS | |||||
Approved colour used. | ||||||
366 | Rosuvastatin and Fenofibrate Tablets | Each film coated tablet contains | ||||
Rosuvastatin Calcium | I.P. | |||||
Eq. to Rosuvastatin | 20 mg | |||||
Finofibrate | I.P. | 160 mg | ||||
Excipients | QS | |||||
Approved colour used. | ||||||
367 | Rosuvastatin, and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
Rosuvastatin Calcium | I.P. | |||||
Eq. to Rosuvastatin | 5 mg | |||||
(As Pellets) | ||||||
Aspirin | I.P. | 75 mg | ||||
(As Enteric Coated Pellets) | ||||||
Excipients | QS | |||||
Approved colour used. | ||||||
368 | Rosuvastatin, and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
Rosuvastatin Calcium | I.P. | |||||
Eq. to Rosuvastatin | 10 mg | |||||
(As Pellets) | ||||||
Aspirin | I.P. | 150 mg | ||||
(As Enteric Coated Pellets) | ||||||
Excipients | QS | |||||
Approved colour used. | ||||||
369 | Rosuvastatin and Ezetimibe Tablets | Each film coated tablet contains | ||||
Rosuvastatin Calcium | I.P. | |||||
Eq. to Rosuvastatin | 5 mg | |||||
Ezetimibe | 10 mg | |||||
Excipients | QS | |||||
Approved colour used. | ||||||
370 | Simvastatin, Ramipril, Atenolol, Hydrochlorthiazide and Aspirin Capsules | Each Hard Gelatin Capsule contains | ||||
Simvastatin | B.P. | 20 mg | ||||
(As Pellets) | ||||||
Ramipril | I.P. | 5 mg | ||||
(As Pellets) | ||||||
Atenolol | I.P. | 50 mg | ||||
(As Pellets) | ||||||
Hydrochlorothiazide | I.P. | 12.5 mg | ||||
(As Pellets) | ||||||
Aspirin | I.P. | 100 mg | ||||
(As Enteric Coated Pellets) | ||||||
Excipients | ||||||
Approved colour used. | ||||||
371 | Amlodipine and Perindopril Tablets | Each film coated tablet contains | ||||
Amlodipine Besylate | I.P. | |||||
Eq. to Amlodipine | 5 mg | |||||
Perindopril Arginine | ||||||
Eq. to Perindopril | 8 mg | |||||
Excipients | QS | |||||
Approved colour used. | ||||||
372 | Amlodipine and Indapamide Tablets | Each film coated tablet contains | ||||
Amlodipine Besylate | I.P. | |||||
Eq. to Amlodipine | 10 mg | |||||
Indapamide | U.S.P. | 1.5 mg | ||||
(As Sustained Release) | ||||||
Excipients | QS | |||||
Approved colour used. | ||||||
373 | Telmisarton, Amlodipine and Hydrochlorothiazide Tablets | Each film coated tablet contains | ||||
Telmisartan | I.P. | 20 mg | ||||
Amlodipine Besylate | I.P. | |||||
Eq. to Amlodipine | 2.5 mg | |||||
Hydrochlorothiazide | I.P. | 6.25 mg | ||||
(As Sustained Release) | ||||||
Excipients | QS | |||||
Approved colour used. | ||||||
374 | Amlodipine and Hydrochlorothiazide Tablets | Each film coated tablet contains | ||||
Amlodipine Besylate | I.P. | |||||
Eq. to Amlodipine | 5 mg | |||||
Hydrochlorothiazide | I.P. | 25 mg | ||||
Excipients | QS | |||||
Approved colour used. | ||||||
375 | Pregabalin and Mecobalamin Capsules | Each Hard Gelatin Capsule contains | ||||
Pregabalin | I.P. | 75 mg | ||||
Mecobalamin | U.S.P. | 750 mcg | ||||
Appropriate overages of Mecobalamin added | ||||||
Excipients | QS | |||||
Approved colour used in capsules shell | ||||||
376 | Pregabalin, Mecobalamin, Pyridoxine, Folic Acid and Benfothiamine Capsules | Each Hard Gelatin Capsule contains | ||||
Pregabalin | I.P. | 150 mg | ||||
Mecobalamin | U.S.P. | 75 mcg | ||||
Pyridoxine Hydrochloride | I.P. | 1.5 mg | ||||
Folic Acid | I.P. | 0.75 mg | ||||
Benfothiamine | 7.5 mg | |||||
Excipients | QS | |||||
Appropriate overages of Vitamins are added | ||||||
Approved colour used in capsules shell | ||||||
377 | Ambroxol, Guaiphenesin and Levosalbutamol Syrup | Each 5 ml contains | ||||
Ambroxol Hydrochloride | I.P. | 30 mg | ||||
Guiphenesin | I.P. | 50 mg | ||||
Levosalbutamol Sulphate | I.P. | |||||
Eq. to Levosalbutamol | 1 mg | |||||
In a mentholated syrupy base | QS | |||||
Approved colour used. |